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90% of proteins carry this mark. Over the last decade, significant progress has been made in elucidating
the function of N-terminal acetylation for a number of diverse systems. The enzymes responsible for this
modification are the N-terminal acetyltransferases (NATs). The NATs are a group of conserved enzymes
in eukaryotes, which can be broadly classified into two groups. The major NATs, NatA-NatC, are
promiscuous and responsible for acetylating the majority of N-termini in the cell, and have hundreds to
thousands of protein substrates. Recently, it has been suggested that they also may target lysine
residues. These NATs largely act co-translationally. They interact with the ribosome near the exit tunnel
and acetylate the nascent protein chain as it is being translated. The other NATs, NatD-NatF, are more
specialized in their substrate specificity and localization patterns.
There is a large amount of structural information on the molecular basis of NAT activity. These studies
have revealed how the NATs are specific for N-termini, and how binding partners affect their activity.
However, the structural characteristics of the specialized NATs remain unknown, the full substrate scope
of NATs remains to be determined, and how the NATs interact with the ribosome is largely unexplored,
despite the importance of this modification in a co-translational context. Therefore, to address these gaps
in knowledge, we determined the crystal structures of NatD and NatF with their substrate peptides bound,
and by carrying out biochemical and enzymological assays, we revealed the molecular basis for their
unique specificity and localization. We also showed that there is no difference in lysine acetylation of
substrate proteins with or without NatA, suggesting that reported substrates are acetylated chemically
rather than enzymatically. Finally, we determined regions on the NatA complex that promote interaction
with the ribosome. This dissertation provides a framework for understanding the molecular basis of the
specialized NATs, and how NATs interact with the ribosome for co-translational protein acetylation. These
studies have implications in developing inhibitors for the specialized NATs, and in understanding cotranslational events in general.
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ABSTRACT

THE MOLECULAR BASIS FOR POST AND CO-TRANSLATIONAL N-TERMINAL
ACETYLATION
Robert S. Magin
Ronen Marmorstein

N-terminal acetylation is among the most common protein modifications in eukaryotic
cells, where up to 90% of proteins carry this mark. Over the last decade, significant progress has
been made in elucidating the function of N-terminal acetylation for a number of diverse systems.
The enzymes responsible for this modification are the N-terminal acetyltransferases (NATs). The
NATs are a group of conserved enzymes in eukaryotes, which can be broadly classified into two
groups. The major NATs, NatA-NatC, are promiscuous and responsible for acetylating the
majority of N-termini in the cell, and have hundreds to thousands of protein substrates. Recently,
it has been suggested that they also may target lysine residues. These NATs largely act cotranslationally. They interact with the ribosome near the exit tunnel and acetylate the nascent
protein chain as it is being translated. The other NATs, NatD-NatF, are more specialized in their
substrate specificity and localization patterns.
There is a large amount of structural information on the molecular basis of NAT activity.
These studies have revealed how the NATs are specific for N-termini, and how binding partners
affect their activity. However, the structural characteristics of the specialized NATs remain
unknown, the full substrate scope of NATs remains to be determined, and how the NATs interact
with the ribosome is largely unexplored, despite the importance of this modification in a cotranslational context. Therefore, to address these gaps in knowledge, we determined the crystal
structures of NatD and NatF with their substrate peptides bound, and by carrying out biochemical
v

and enzymological assays, we revealed the molecular basis for their unique specificity and
localization. We also showed that there is no difference in lysine acetylation of substrate proteins
with or without NatA, suggesting that reported substrates are acetylated chemically rather than
enzymatically. Finally, we determined regions on the NatA complex that promote interaction with
the ribosome. This dissertation provides a framework for understanding the molecular basis of the
specialized NATs, and how NATs interact with the ribosome for co-translational protein
acetylation. These studies have implications in developing inhibitors for the specialized NATs,
and in understanding co-translational events in general.
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CHAPTER 1: In the beginning: N-terminal Acetylation
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1.1 Protein modifications

Determining the genetic code was a triumph of 20th century science, and marked the
beginning of modern molecular biology. However, it is clear that the proteinogenic amino acids
do not account for all of the diversity of protein structure and function. There are a number of
ways in which proteins can escape from the chemical space imposed on them by the genetic code.
Non-canonical amino acids, such as selenocysteine and pyrrolysine, known as the 21st and 22nd
amino acid, can be incorporated into directly into proteins during translation in the context of
repurposed stop codons in the mRNA (Yuan et al. 2010). Many proteins employ organic and
inorganic cofactors to substantially increase the diversity of the chemistry they perform
(Denessiouk, Rantanen, and Johnson 2001). However, modifications to the side chains
themselves are among the most powerful means to affect protein structure and function
(Prabakaran et al. 2012).
Modifications to protein side chains have been studied for decades and are widespread
and diverse in their chemistries and functions (Figure 1.1) (Verdin and Ott 2015; Fischer et al.
1959). Acetylation, phosphorylation, methylation are among the most commonly studied
modifications, although hundreds have been described (Shortreed et al. 2015). These three
modifications often act as binary switches, which toggle a protein between two different states.
These switches may affect enzyme inactivation/activation, modulation of protein interactions,
multimeric states of a protein, or localization (Prabakaran et al. 2012; Cain, Solis, and Cordwell
2014; Seet et al. 2006). Other modifications will change the chemical reactivity of a side chain,
such as generating formylglycine from cysteine or serine (Appel and Bertozzi 2015), and
carbamylation of lysines (Hsieh et al. 2013). Other modifications that attach large side-chains like
ubiquitin and complex sugar moieties give rise to new signaling pathways and recognition sites
2

for other proteins (Yau and Rape 2016; Spiro 2002). Utilizing protein modifications allows for
rapid control of cellular processes, expanded chemistry beyond the canonical amino acids, and
dynamic regulatory power.

Figure 1.1 Chemical diversity of protein modifications
Figure taken from (Ribet and Cossart 2010)
1.2 Acetylation

Acetylation is among the most common protein modifications. This occurs when acetylCoA transfers an acetyl group to a lysine side chain (Figure 1.2A), or N-terminus of a protein
(Figure 1.2B) (Verdin and Ott 2015). Acetylation changes the physicochemical properties of the
side chain or N-terminus of the protein. It does this by increasing the hydrophobicity of the sidechain, neutralizing the positive charge, and adding a carbonyl group capable of serving as a
hydrogen bond acceptor.

3

Figure 1.2 Protein acetylation
(A) Schematic of lysine acetylation (B) Schematic of N-terminal acetylation (C) Structure of
acetyl-CoA with component parts indicated

4

In the language of protein modifications, the nomenclature of “writers,” “readers,” and
“erasers” is often used to describe the enzymes which attach the modification, the domains
responsible for binding to the modified side-chain and affecting function, and the enzymes which
remove the modification, respectively (Pande 2016). All of these proteins have been described for
the process of lysine acetylation (Figure 1.3). There is a large family of acetyltransferases found
in all domains of life. These enzymes utilize acetyl-CoA as an acetyl donor to acetylate their
cognate protein substrates (Figure 1.2C). These include the GCN5 family, the MYST family, and
the HAT1 family. These enzymes all share a common acetyl-CoA binding core, and differ in their
substrate binding and regulatory regions (Marmorstein 2001). The readers of acetylation include
bromodomains and YEATS domains (Marmorstein and Zhou 2014). Finally there is a large
families of enzymes which deacetylate acetyl-lysines, the HDACs, which have been extensively
characterized (Haberland, Montgomery, and Olson 2009). Importantly, all of these proteins are
often found in large complexes with binding partners that can regulate their localization, stability,
and substrate specificity (McCullough and Marmorstein 2016).
Most famously, acetylation affects histone tails and prevents them from forming
electrostatic interaction with DNA, thus serving to decompact chromatin (Figure 1.3) (Verdin and
Ott 2015). Indeed, much of the literature regarding acetylation focuses on histone modifications
and the effect this has on gene expression. However, despite this focus, acetylation is a
widespread and ancient protein modification, which is now appreciated to affect thousands of
substrate proteins throughout the cell (Choudhary et al. 2014).

5

Figure 1.3 Effectors of acetylation
Protein acetylation is most widely studied in the context of chromatin compaction and gene
expression through the acetylation of histone tails. Writers are acetyltransferases which make the
mark, readers are effector domains that relay signals about the state of the tail, and erasers are
deacetylases that remove the mark. Note that this paradigm has been expanded far beyond
histones and is now recognized as a major PTM in the entire proteome. This figure was adapted
from (Verdin and Ott 2015)
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1.3 N-terminal acetylation

Although less studied than lysine acetylation, N-terminal acetylation was observed as
early in 1958, when Kozo Narita noted an N-terminal serine in a digested protein sample from
tobacco mosaic virus (Narita 1958). It was subsequently found in many other diverse proteins
(Strous, Westreenen, and Bloemendal 1973; Pestana and Pitot 1974; Strous, Berns, and
Bloemendal 1974; Kasten-Jolly and Taketa 1982), and as researchers looked, it was noted to be
very common (Brown and Roberts 1976; Polevoda, Norbeck, and Takakura 1999). With the
power of proteomics, it became clear that N-terminal acetylation is a widespread modification in
eukaryotic cells, and is the exception rather than the rule. Depending on the organism 50-90% of
soluble proteins are N-terminally acetylated (Van Damme, Evjenth, et al. 2011; Van Damme et
al. 2012). Thus, within eukaryotes, N-terminal acetylation is one of the most common
modifications that occur on proteins.
The reason for this widespread modification is still unclear. Initially it was thought that
such a common modification likely leads to a common functional outcome for all proteins which
are affected, and it was hypothesized that the modification generally acted to protect proteins
from degradation (Jornvall 1975). However, this was disproven when it was found that the
presence of an acetyl group did not change the stability of a large sample of proteins in cellulo
(Brown 1979). In fact, Varshavsky and colleagues have shown that acetylated N-termini act as Ndegrons, and can promote protein degradation through the ubiquitin system (Figure 1.4) (Hwang,
Shemorry, and Varshavsky 2010). In this way, they argue that N-terminal acetylation acts as
quality control in subunit stoichiometry, as in the case of the APC/C subunits Hcn1 and Cut9
(Shemorry, Hwang, and Varshavsky 2013), and that the general function is largely in the
degradation of proteins in the cell (Park et al. 2015). As N-terminal acetylation is irreversible
7

(Aksnes et al. 2016), this suggests that proteins are immediately marked for degradation when
they are translated. However, this claim has only been definitely shown for a handful of proteins,
and whether it indeed is a general function of N-terminal acetylation remains to be seen.
There are many other functional consequences of N-terminal acetylation that are limited
to specific systems (Figure 1.4). N-terminal acetylation can mediate protein-protein interactions.
It promotes the interaction of the E2 ligase Ubc12 with Dcn1 to promote neddylation of cullins
(Scott et al. 2011; Scott et al. 2014), and enhances the interaction of the chromatin regulatory
protein Sir3 with the nucleosome (Arnaudo, Fernández, and McLaughlin 2013). N-terminal
acetylation can affect protein localization, as it ensures Golgi localization for the GTPase Arl3p
(Behnia et al. 2004), and membrane localization for alpha-synuclein (Dikiy and Eliezer 2014). It
also has been shown to have an influence on whether proteins enter the secretory pathway.
Cytosolic proteins are enriched for N-acetyl groups, and whether or not an N-terminus is
acetylated can affect whether is enters the secretory pathway or not (Forte, Pool, and Stirling
2011). Finally, N-terminal acetylation is implicated in protein folding and aggregation. A
knockout of NatA in yeast cells showed a global increase in misfolded proteins and chaperone
levels (Holmes et al. 2014). In human cells, both the chaperone HYPK, which stably associates
with the NatA complex, and the NatA complex itself help prevent aggregation of hutingtin
(Arnesen et al. 2010).
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Figure 1.4 Functional consequences of N-terminal acetylation
An overview of some effects of N-terminal acetylation. (1) Acetylation creates degradation
signals for some proteins through the Ac/N-end rule pathway. (2) Protein-protein interactions
may be enhanced depending on the presence of an acetyl group. (3) Protein localization can
depend on an N-terminal acetyl group through protein-protein interaction or protein-membrane
interactions. (4) Proteins that are N-terminally acetylated are less likely to go through the
secretory pathway. (5) Protein folding and aggregation is affected by N-terminal acetylation. This
figure was adapted from (Aksnes et al. 2016)
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Although it is the most widespread, N-terminal acetylation is only one of many
modifications that occur on the N-termini of proteins. Another quite common modification is
initial methionine excision by methionine aminopeptidases, a process that is conserved
throughout all domains of life (Lowther and Matthews 2000). This occurs when the second
residue in a peptide has a small side-chain (Ala, Cys, Gly, Pro, Thr, or Val). More specialized Nterminal modifications include N-terminal myristoylation (Xu et al. 2015), N-terminal
methylation (Dong et al. 2015), and N-terminal arginylation (Kashina 2014). These processes
occur on a smaller subset of proteins than N-terminal acetylation, and have different functional
consequences. N-terminal myristoylation is essential for proper protein localization to
membranes, and can also be important for the structural integrity of some proteins. N-terminal
arginylation creates a degradation signal on a protein, as an arginine at the N-terminus of a
protein is destabilizing via the N-end rule (Tasaki et al. 2012). It has also been studied in other
contexts, and has other cellular and functional consequences. N-terminal methylation is less
studied, and its role remains unclear.

1.4 N-terminal acetyltransferases (NATs)

N-terminal acetylation is carried out by a family of enzymes called N-terminal
acetyltransferases (Aksnes et al. 2016). There are six NAT complexes which are universally
present in eukaryotes, and all of them were likely present in the last common eukaryotic ancestor
(Rathore, Faustino, and Prudêncio 2016). They also have homologs in bacteria and archaea, but
N-terminal acetylation is not as widespread in these domains of life (Vetting et al. 2008; Liszczak
and Marmorstein 2013). These enzymes are designated NatA-NatF (Figure 1.5). The
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nomenclature of the NATs and their subunits are presented in Table 1.1. The NATs differ in their
N-terminal substrate specificity, and can be separated into the major NATs and the minor NATs.

Table 1.1 Nomenclature of NAT subunits
NAT

Catalytic Subunit

Auxiliary Subunit

Additional subunits

NatA

Naa10

Naa15

Naa50, HYPK

NatB

Naa20

Naa25

NatC

Naa30

Naa35

NatD

Naa40

NatE

Naa50

NatF

Naa60

Naa38
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Figure 1.5 The N-terminal acetyltransferase (NAT) Family
Subunit composition, substrate specificity, and localization of the NATs. (A) The major NATs,
which are responsible for acetylating the majority of the proteome. (B) The other NATs have
more limited substrate profiles, or specialized localization. NatA-E are shown associated with the
ribosome (discussed below). This figure was adapted from (Aksnes et al. 2016)
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The three major NATs are NatA, B, and C, which are responsible for acetylating the vast
majority of N-termini in the cell (Figure 1.5A). The major NATs are comprised of a catalytic
subunit, and a larger auxiliary subunit that is necessary for catalysis. Some have additional
binding partners. These can be other NATs, like Naa50, or regulatory proteins like HYPK, both
of which bind to NatA. NatA, B, and C all bind to the ribosome and act to co-translationally
modify nascent N-termini as they emerge from the ribosome exit tunnel (discussed more in
section 1.5). Each has hundred of substrates and recognizes N-termini based on the first two
residues. NatA recognizes N-termini with small residues (Ala, Cys, Gly, Ser, Thr, Val) at their Nterminus after the initial methionine (iMet) has been cleaved by methionine aminopeptidase.
NatB acetylates substrates with an iMet followed by an acidic residue or their corresponding
amides, and NatC acetylates N-termini with an iMet followed by large hydrophobic residues. It
has been reported that in addition to their promiscuity in the number of N-terminal substrates they
have, that the catalytic subunits of some NATs target lysine residues as well, without interacting
with their auxiliary binding partners (Dorfel and Lyon 2015). If true, this would significantly
expand the substrate scope of the NATs. This is a controversial claim in the field, and has been
challenged by many groups (Arnesen et al. 2005; Murray-Rust et al. 2006).
The other NATs are more specialized in their substrates specificities and localization
(Figure 1.5B). These NATs do not require an auxiliary subunit in order to be catalytically active
(Aksnes et al. 2016). NatD stands out from all of the other NATs with its stringent specificity; it
only has two known substrates, histones H2A and H4, which both start with the sequence
SGRGK (Polevoda, Hoskins, and Sherman 2009). How NatD is so specific while the other NATs
are promiscuous is an open question. Naa50 associates with the NatA complex, and is require for
chromosome segregation, potentially through acetylating Scc1, a subunit of the cohesin complex
(Ribeiro et al. 2016). Naa60 is also unique in that it localizes to the Golgi and primarily acetylates
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the N-termini of membrane proteins (Aksnes, Van Damme, Goris, Starheim, Marie, Støve, et al.
2015). Both Naa50 and Naa60 recognize the iMet of a peptide but have a broader flexibility in the
residue in the second position, and the full scope of their in vivo substrates is yet to be
determined.
Over the last five years, a large amount of work has been done to establish the structural
basis for the activity of the NATs (Liszczak et al. 2013; Liszczak and Marmorstein 2013; Magin,
Liszczak, and Marmorstein 2015b; Støve et al. 2016; Hong et al. 2017; Weyer et al. 2017). The
NATs belong to the GNAT superfamily of acetyltransferases. The superfamily fold is
characterized by a mixed alpha-beta arrangement, in which alpha helical regions surround a
central beta sheet made up of seven beta strands (Figure 1.6). There is a conserved acetyl-CoA
binding site in the core of the enzyme comprised of two beta strands and an alpha helix. The
substrate-binding site varies between different acetyltransferases. It is comprised of two alpha
helical/loop regions that flank the core of the enzyme. These regions mediate the substrate
specificity of the acetyltransferase. In classical histone acetyltransferases, the peptide-binding site
is wide and can accommodate an extended peptide that inserts a lysine close to the acetyl group in
the acetyl-CoA to be acetylated (Figure1.6A and 1.6C) (Rojas et al. 1999). In all NAT structures
solved to date, however, the binding site is occluded by the β6-β7 loop, which sterically blocks
peptides from lying across the active site (Figure 1.6B and 1.6D, Figure 1.7). N-termini, however,
can easily access the active site, as they are at the end of the polypeptide chain. In this way, the
NATs show high preference to N-termini rather than lysines, which conflicts with reports that
they possess lysine acetyltransferase activity. In addition to the steric blockage of the active site,
there is a conserved motif of two tyrosines in the β6-β7 loop which hydrogen bond to the
backbone amides of the N-terminus in the NAT, further stabilizing the interaction of the N-
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terminus with the enzyme. All of the NAT structures solved to date orient the peptide in the same
manner from the active site (Figure 1.8).

Figure 1.6 The NATs have a sterically hindered peptide binding site
(A) Structure of a classical histone acetyltransferase, GCN5 (PDB: 1QSN) as a blue cartoon, and
H3 peptide in cyan sticks. (B) Structure of Naa10 (PDB: 4KVM) as an orange cartoon, and SASE
peptide as wheat sticks. Note the indicated β6-β7 loop in Naa10.
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Figure 1.6 (continued from previous page): (C) Surface view of GCN5 with H3 peptide. (D)
Surface view of Naa10 with SASE peptide.
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Figure 1.7 Superposition of NAT structures
Superposition of solved NAT crystal structures. All are shown as cartoon. Naa10 (PDB: 4KVM)
is in orange, Naa50 (PDB: 3TFY) is in cyan, ssNAT (PDB: 4LX9) is in purple, and the bacertial
NAT RimI (PDB: 2CNM) is in blue.
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The NATs use an ordered, sequential mechanism, which is typical for the GNAT family
of acetyltransferases (Evjenth et al. 2009). Unlike the MYST family, which utilize a catalytic
cysteine in a ping-pong mechanism (Yuan et al. 2012), the NATs all form ternary complexes with
both acetyl-CoA and the substrate peptides. Interestingly, the position and residue identity of the
general base in NATs is quite variable (Figure 1.8). In the structure of a bacterial NAT, RimI, the
general base is E103 in β5 (Figure 1.8A) (Vetting et al. 2008). In Naa50, a water molecule
oriented by Y73 in β4 and H112 in β5 acts as a general base (Figure 1.8B) (Liszczak, Arnesen,
and Marmorstein 2011). In Naa10, the situation is more ambiguous (Liszczak et al. 2013). E24 in
the α1-α2 loop was found to be essential for catalysis (Figure 1.8C). However, this residue is not
in a position to directly deprotonate the N-terminus, making its status as a general base come into
question. For Naa10, it may instead be acting to orient the N-terminus, or polarize it to be more
nucleophilic. Since the N-termini of proteins tend to have a lower pKa than lysine side chains on
average, utilizing a residue as a general base is potentially not as critical for the NATs as lysine
acetyltransferases. Interestingly, in the structure of a NAT from the archaea Sulfolobus
solfataricus (ssNAT), there are three catalytic residues: E84 in the α1-α2 loop, H137 in β4, and
E176 in β5 that allow the enzyme to act on both serine-initiating peptide, and methionineinitiating peptides (Figure 1.8D) (Liszczak and Marmorstein 2013). Thus, ssNAT uses a
combination of catalytic residues seen in the other NATS to acetylate a broad substrate profile.
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Figure 1.8 The position and identity of the catalytic residue(s) differs between NATs
All structures in this figure are shown as cartoons, with their substrate peptide as white sticks.
The tyrosines in the β6-β7 loop are shown as sticks, as is the tyrosine in the α1-α2 loop
(tryptophan in RimI) (A) Structure of the bacterial NAT RimI in blue, with general base E103
labeled and shown as sticks (B) Structure of Naa50 in cyan, with general bases Y73 and H112
labeled and shown as sticks (C) Structure of Naa10 in orange, with catalytic residue E24 labeled
and shown as sticks (D) Structure of ssNAT in purple, with general bases E84, H137, and E176
labeled and shown as sticks.
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Finally, while there is less information about the NATs in complex with their auxiliary
subunits, the structure of the heterodimeric NatA complex is available (Liszczak et al. 2013). The
structure reveals an intimate interaction between Naa10 and Naa15, with Naa15 wrapping around
Naa10 in a molecular “nest,” that modulates the activity of the enzyme (Figure 1.9). This
complex will be discussed more thoroughly in chapter 5.

1.5 Co-translational modifications

It has long been known that N-terminal acetylation is largely a co-translational process
(Gautschi et al. 2003). Experiments conducted over 30 years ago showed that nascent N-termini
isolated from ribosomes were acetylated with as few as 25 residues translated (Strous,
Westreenen, and Bloemendal 1973; Pestana and Pitot 1974; Strous, Berns, and Bloemendal
1974). More recently, NatA, B and C have all been shown to interact with the ribosome through
their auxiliary subunits in both yeast and human cells (Figure 1.5A) (Polevoda et al. 2008). For
NatA, this interaction is salt dependent, and a pull down from a yeast system indicated ribosomal
proteins L23 (Rpl25p) and L29 (Rpl35p) in the NatA interaction (Polevoda et al. 2008). Both of
these proteins are found near the peptide exit tunnel in the 60S subunit of the ribosome.
Moreover, N-terminal acetylation has also been shown to compete with signal recognition
particle (SRP) targeting, further suggesting a dynamic interplay of various ribosomal binding
proteins which are in involved in N-terminal processing (Forte, Pool, and Stirling 2011).
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Figure 1.9 Structure of the NatA complex
Naa15 is shown in green, Naa10 is shown in cyan, and the substrate peptide is shown in magenta
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In addition to N-terminal acetylation, there are a number of other well known cotranslational processes and modifications (Figure 1.10) (Giglione, Fieulaine, and Meinnel 2015).
These include translational stalling and localization to the endoplasmic reticulum by the SRP for
transmembrane proteins, or those destined for the secretory pathway (Akopian et al. 2013). Other
co-translational modifications include iMet removal by methionine aminopeptidases (MAP),
methionine deformylation in bacteria by peptide deformylases (PDF), and N-terminal
myristoylation by N-terminal myristoylases (Giglione, Fieulaine, and Meinnel 2015). The two
enzymatic processes that are most analogous to N-terminal acetylation are MAP activity and PDF
activity. Both are very widespread, and occur on a high percentage of all proteins that are
translated (Kramer et al. 2009). These two proteins both directly interact with the ribosome and
are also both highly dynamic with a high on/off rate for association with the ribosome (Sandikci
et al. 2013; Bingel-Erlenmeyer et al. 2008).
In addition to these enzymatic events, there are a number of protein chaperones which
bind to the emerging polypeptide at the ribosome exit tunnel to assist in co-translational folding
(Kramer et al. 2009). These include trigger factor in bacteria (Kramer et al. 2002; Maier et al.
2003), NAC and the Ssb/Ssz/Zuotin triad in eukaryotes (Wiedmann et al. 1994; Gautschi et al.
2002). Thus, the nascent N-terminus immediately encounters a number of factors involved in its
processing as soon as it reaches the end of the exit tunnel. Importantly, all of these proteins are
believed to directly interact with the ribosome. Although the detailed molecular basis for these
interactions are not known for all of the factors, there do seem to be commonalities. The
ribosomal protein L23 acts as an important docking site for SRP, trigger factor, NAC, and NatA,
and many proteins use electrostatic interactions to interact with the ribosome, with both the rRNA
and a conserved negatively charged patch found on a surface exposed region of L23 (Schaffitzel
et al. 2006; Wegrzyn et al. 2006; Kramer et al. 2002; Becker et al. 2009; Ataide et al. 2011).
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Figure 1.10 Co-translational modifications
Overview of co-translational modifications in bacteria and eukaryotes. Abbreviations are as
follows: PDF- peptide deformylase, MetAP- methionine aminopeptidase, Nat- N-terminal
acetyltransferase, NMT- N-myristoyltransferase. This figure was adapted from (Giglione,
Fieulaine, and Meinnel 2015)
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1.6 NATs in development and disease

As NATs have so many substrates and affect a wide variety of cellular processes, it is
perhaps not surprising that the misregulation of NAT activity is implicated in a wide variety of
developmental defects and diseases. Many genetic disorders have been described which affect the
Naa10 subunit of the NatA complex. One such mutation, S37P, causes Ogden Syndrome, an Xlinked syndrome which causes cardiac arrhythmias, an aged appearance, developmental delays,
and is ultimately fatal by the third year of life (Rope et al. 2011). Other disorders with different
mutations have been described, but share common phenotypes of intellectual disability, cardiac
abnormalities, and developmental delay (Casey et al. 2015; Popp et al. 2015; Saunier et al. 2016).
These disorders affect the client population of proteins which are acetylated in the cell
(Myklebust et al. 2015). The fact that there is such a wide variety of substrates in the cell which
are affected by N-terminal acetylation means that it is likely that the causes of these disorders
arise from a complex combination of aberrant protein processing.
In addition to genetic disorders, N-terminal acetylation has also been implicated in a
number of cancers (Dorfel and Lyon 2015). These studies have yielded varying results about the
effects of knocking out N-terminal acetylation. Overall, the effects can promote apoptosis, or
prevent it, and the various tissues, cellular and proteomic context in which these changes occur
likely affect the outcome of aberrant N-terminal acetylation (Pavlou and Kirmizis 2016; Wang et
al. 2012; Yang et al. 2016; Zeng et al. 2014). More research will be required to define the role
that this process plays in cancer formation and apoptosis.
These factors have made N-terminal acetylation an attractive target for disease treatment.
Bisubstrate inhibitors have been developed, which covalently link an N-terminal like peptide to a
non-hydrolyzable CoA moiety (Foyn et al. 2013). These bisubstrate inhibitors have proved
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extremely valuable in research applications and will hopefully set the stage for therapeutic uses in
the treatment of disease.

1.7 Dissertation objectives

Although a great deal of work has been done elucidating the molecular basis of Nterminal acetylation, there are still many unanswered questions in the field. These concern both
the specialized NATs, and the major, promiscuous NATs. The structural features of the more
specialized NATs are unknown, and the molecular basis underlying their specificity and
localization remains to be explored. What confers the stringent specificity to Naa40 compared to
the other more promiscuous NATs? Are there unique special features of Naa60 which allow it to
act differently at the Golgi versus the cytosolic NATs. Why are these proteins able to catalyze
reactions without auxiliary subunits?
Similar questions arise for the more promiscuous NATs. If they are actually able to
acetylate lysine residues, how does this occur? Are there structural changes that accompany a
lysine position in the active site, and if so, are there specific sequence determinants that guide the
lysine substrate profile? Finally, how do the NATs associate with the ribosome? Do they compete
for the same binding spot or occupy different positions around the exit tunnel simultaneously?
What are the molecular determinants on the NATs that allow them to interact with the ribosome,
and what is the nature of the interaction? Answering these questions will allow for a broader
understanding of the NATs from a structural standpoint that will help understand the function of
the specialized NATs, and increase our understanding of co-translational events in the cell. These
studies will potentially aid in the development of new research tools and therapeutics that can be
applied to not only the NATs, but other systems as well.
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The focus of my dissertations is to probe the mechanism of action and substrate
recognition of the NATs, in both a post and co-translational context. To this end, I determined the
crystal structure of Naa60 and Naa40 in complex with their substrate peptides, and carried out
mutational and enzymological analysis of the enzymes. I assayed the ability of the Naa10 to
acetylate lysine residues, using enzymatic and biochemical means. Finally, I probed the
interaction of NatA with the ribosome using purified proteins. Through these studies I was able
to:
(1) Characterize the unique features of Naa60 that may influence its localization and
substrate specificity
(2) Show how Naa40 is able to maintain exquisitely substrates selectivity by varying the
NAT fold with novel features
(3) Demonstrate that Naa10 is not able to acetylate its reported lysine substrates, which
instead represent a group of proteins that are chemically acetylated
(4) Find two regions in the NatA complex that are essential for ribosome binding and
have implications for the mechanism the other NATs may bind to the ribosome
The last chapter of my dissertation is more speculative. There, I discuss a hypothesis on the
evolution of the NATs based on an emerging model of eukaryogenesis and the implications this
has for how we think about N-terminal acetylation.
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CHAPTER 2: Crystal Structure of the Golgi-Associated Human Naa60 Reveals the
Molecular Determinants for Substrate-Specific Acetylation

This research was performed in collaboration with Dr. Svein Støve from the University of
Bergen. Dr. Støve solely performed all of the enzymatic and DSF assays. This work was
originally published in Structure (Støve et al. 2016) © Cell Press
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2.1 Introduction
Naa60 is the most recently identified and least studied NAT. Naa60 is distinct in its
subcellular localization pattern; while Naa10–Naa50 are located throughout the cytoplasm and in
some cases also in the nucleus, Naa60 displays an organellar localization pattern associating with
Golgi membranes (Aksnes, Van Damme, Goris, Starheim, Marie, Stove, et al. 2015). Depletion
of NAA60 results in Golgi fragmentation in HeLa cells (Aksnes, Van Damme, Goris, Starheim,
Marie, Stove, et al. 2015) and abnormal chromosome segregation in drosophila DmeI2 cells (Van
Damme, Hole, et al. 2011a), resembling the observed phenotypes of NAA50 depleted drosophila
cells. Interestingly, although Naa60 is present in most eukaryotes, it has been lost in the fungi
lineage. This is why it was initially believed to only be present in multicellular eukaryotes, as it
was absent in the model organism Saccharomyces cerevisiae. (Van Damme, Hole, et al. 2011b;
Rathore, Faustino, and Prudêncio 2016).
Initial studies of human Naa60 suggested that although there was extensive redundancy
in the substrate specificity profile of Naa30, Naa50 and Naa60 in vitro, there is a large overrepresentation of transmembrane proteins in the Naa60 acetylome, suggesting that Naa60 has
evolved to specifically acetylate the cytosolic N-termini of membrane proteins from its
membrane-associated localization (Aksnes, Van Damme, Goris, Starheim, Marie, Stove, et al.
2015). Additionally, unlike the other NATs, Naa60 can efficiently acetylate MK starting peptides,
a class of substrates that are not acetylated in yeast, but are in animal cells (Van Damme, Hole, et
al. 2011b).
In this study, we set out to investigate the structure and biochemical properties of human
Naa60. To this end, we cloned, purified and crystallized Naa60 both in complex with CoA and in
complex with a bisubstrate analogue closely resembling CoA and an acetylated substrate
polypeptide. We also carried out structure-based mutagenesis and biochemical and enzymatic
studies in order to make structure-function correlations underlying Naa60-specific activities. The
28

Naa60 structure adopts a Gcn5-related N-acetyltransferases fold, but contains extended β3-β4 and
β6-β7 loops that we demonstrate are important for Naa60 function. By the use of site directed
mutagenesis and kinetic analysis we show that Naa60 employ a catalytic mechanism similar to
Naa50, while the β3-β4 and β6-β7 loops play important roles in substrate-specific binding, and
that the latter loop also mediates a dimer to monomer transition. Collectively, the data presented
here reveal the molecular basis for Naa60-specific acetyltransferase activity with implications for
Golgi-specific functions for this multicellular-specific NAT.

2.2 Results
2.2.1 Structure of Naa60/CoA-Ac-MKAV7 reveals Naa60-specific regions
Sequence alignment of human Naa60 with other NAT homologues reveals sequence
homology within the N-terminal 180 amino acids (Figure 2.1), but sequence divergence of Cterminal residues 181-242 that have been shown to be responsible for the Golgi subcellular
localization of Naa60 (Aksnes, Van Damme, Goris, Starheim, Marie, Stove, et al. 2015; Aksnes
et al. 2017). Within the conserved NAT region, Naa60 shows the greatest regions of sequence
divergence in the β3-β4 (residues 73-94) and β6-β7 (residues 165-173) loops, which are also
longer in Naa60 than other eukaryotic NATs. Interestingly, the β3-β4 loop of the NAT
homologue from Sulfolobus solfataricus (ssNAT) is also extended compared to β3-β4 loops of
other NATs, and was previously shown to be important for ssNAT function (Liszczak and
Marmorstein 2013).
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Figure 11 Sequence alignment of selected NATs
(A) Sequence alignment of Naa60 (1–184) and NAT homologs. Sequence identity is shown with
white letters in red boxes and sequence similarity with red letters in blue frames. The secondary
structure elements of Naa60 are shown on top of the alignment. The β3-β4 loop is marked in pink
and the β6-β7 loop in light blue. (B) IC50 values of the two bisubstrate analogs CoA-AcMAPL7 and CoA-Ac-MKAV7 in addition to the control compound desulfoCoA. (C) Overall
structure of the binary Naa60/CoA-Ac-MKAV7 complex. Naa60 is shown in yellow, the β3-β4
loop is shown in pink (on the back side of the structure), the β6-β7 loop in light blue, and the
CoA-Ac-MKAV7 inhibitor is shown as green sticks with oxygen, nitrogen, and phosphate shown
in red, blue, and orange, respectively.
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In order to structurally and biochemically examine human Naa60, we cloned, expressed
and purified different N-terminal Naa60 variants and were able to prepare a construct containing
residues 1-184, which was amenable to biochemical and structural analysis. We also prepared
two bisubstrate analogues, CoA-Ac-MAPLDLD (CoA-Ac-MAPL7) and CoA-Ac-MKAVQAD
(CoA-Ac-MKAV7) derived from previously identified N-terminal Naa60 in vivo substrates (Van
Damme, Hole, et al. 2011a; Aksnes, Van Damme, Goris, Starheim, Marie, Stove, et al. 2015).
Both bisubstrate analogues were very potent inhibitors, with a half maximum inhibitor
concentration (IC50) of 1.0 ± 0.1 µM and 2.44 ± 0.6 µM, respectively, whereas the IC50 of
desulfoCoA was 394.7 ± 43.3 µM (Figure 2.2A).
We obtained crystals of Naa60 (5-184) in binary complex with CoA-Ac-MKAVQAD
and to determine its structure to a resolution of 1.53 Å, using molecular replacement with ssNAT
(PDB ID: 4LX9) as a search model. The crystals formed in spacegroup P41 and contained two
Naa60/CoA-Ac-MKAV7 complexes per asymmetric unit. The resulting electron density allowed
for the tracing of residues 5-184 of Naa60, and the CoA-Ac portion and residues 1 to 4 of the
bisubstrate inhibitor (herein called CoA-Ac-MKAV7). Both complexes in the asymmetric unit
overlay almost perfectly except for a slight adjustment of the side chain positions of M1p and K2p
of the bisubstrate inhibitor. The final model was refined to an Rwork/Rfree of 0.1905/0.2084 with
good geometry (Table 2.1). We also obtained crystals and determined the structure of Naa60 in
complex with CoA (more thoroughly described below). Naa60 adopts the characteristic GNAT
(Gcn5-related N-acetyltransferase) fold found in all NATs, consisting of a mixed α/β fold with a
conserved AcCoA binding site (Figure 2.2B). In contrast, the β3-β4 and β6-β7 loops adopt
Naa60-specific structures. The β3-β4 loop folds back towards the peptide and core domain, and
the β6-β7 loop, contains a β-hairpin structure with two shorts strands that we call β6’ and β7’ that
hangs over the peptide binding site in a manner that is highly characteristic for all NATs (Figure
2.2B).
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Figure 12 Overall Structure of the Binary Naa60/CoA-Ac-MKAV7 Complex
(A) IC50 values of the two bisubstrate analogs CoA-Ac-MAPL7 and CoA-Ac-MKAV7 in addition
to the control compound desulfoCoA. (B) Overall structure of the binary Naa60/CoA-AcMKAV7 complex. Naa60 is shown in yellow, the β3-β4 loop is shown in pink (on the back side
of the structure), the β6-β7 loop in light blue, and the CoA-Ac-MKAV7 inhibitor is shown as
green sticks with oxygen, nitrogen, and phosphate shown in red, blue, and orange, respectively.
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Table 2.1 Data Collection and Refinement Statistics
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2.2.2 Naa60 shows the greatest structural and functional similarity to Naa50
A superposition of the Naa60/CoA-Ac-MKAV7 structure with other NAT structures
shows the highest degree of structural similarity to Naa50 (PDB: 3TFY) with an RMSD of 1.59 Å
for backbone atoms, although there is still significant structural superposition with Naa10 (PDB:
4KVM) (RMSD = 1.96 Å) and ssNAT (PDB: 4LX9) (RMSD = 1.70 Å) (Figure 2.3A). Consistent
with the sequence divergence between these proteins, Naa60 shows the greatest structural
divergence with these proteins in the β3-β4 and β6-β7 loops (Figures 2.3B and 2.3C).
Interestingly, the β3-β4 loop of ssNAT is most similar to the corresponding loop of Naa60 and
has previously was shown to be important for ssNAT function by hanging over and contacting the
β5, β6, β7 strands to position residues in these strands to make peptide substrate interactions
(Liszczak and Marmorstein 2013). As discussed below, this loop plays a similar role in Naa60.
As expected, two tyrosine residues in the β6-β7 loop of Naa60 (Y164 and Y165) are conserved
and play a role in peptide anchoring (Figure 2.3C).
A superposition of the Naa60/CoA-Ac-MKAV7 structure with other NAT structures also
reveals that the active site of Naa60 most closely resembles the active site of Naa50, in which two
residues contribute to general base catalysis. In Naa50, these residues are Y73 and H112 and the
corresponding residues in Naa60 are Y97 and H138 (Figure 2.4A). Both structures also show an
ordered water molecule in a similar position to facilitate proton extraction from the target amine.
The water molecule is coordinated by the side chain of Y97, backbone carbonyl of L98, backbone
nitrogen of H138, and M1p N-terminus (Figure 2.4A).
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Figure 13 Structural Alignment Highlighting Specific Features of Naa60
(A) Superimpositon of Naa60 (yellow) with Naa50 (cyan), SpNaa10 (orange), and ssNAT
(white). CoA-Ac-MKAV7 bound to Naa60 is shown as green sticks. (B) Superimposition of
Naa60 (yellow), Naa50 (cyan), SpNaa10 (orange), and ssNAT (white) β3-β4 loop. (C)
Superimposition of Naa60 (yellow), Naa50 (cyan), SpNaa10 (orange), and ssNAT (white) β6-β7
loop containing a hairpin structure with two short strands (β6′ and β7′).
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Figure 14 Catalytic Mechanism and Peptide Binding Site of Naa60 (from previous page)
(A) Superimposition of the Naa60 and Naa50 active site (shown in yellow and cyan,
respectively). Residues associated with catalysis (Y97, H138 of Naa60 and Y73, H112 of Naa50)
are shown as yellow and cyan sticks. An ordered water molecule involved in catalysis is shown in
yellow and cyan for the Naa60 and Naa50 structure, respectively. The bisubstrate analog CoAAc-MKAV7 is shown as green sticks in all figures. (B) Residues F34, P35, I36, L140, Y165, and
I167 (yellow sticks) form a hydrophobic pocket surrounding the substrate peptide M1p side chain.
(C) Structural alignment of Naa60 and Naa50 active sites. Residues L99, Y38, and Y165 of
Naa60 that play important roles in peptide anchoring and are structurally conserved between
Naa60 and Naa50 are shown as yellow sticks. Hydrogen bonds are illustrated as dashed lines. (D)
Superimposition of the cavity surrounding the Naa60 and Naa50 peptide binding site. (E) Active
site surface representation of Naa60. (F) Active site surface representation of Naa50.
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In addition to similarities in the active site, Naa60 and Naa50 both contain a conserved
hydrophobic core that recognize Met1 of the cognate N-terminal substrate. Specifically, F34, P35,
I36, L140, Y165 and I167 of Naa60, which are conserved in Naa50, surround the side chain of
M1p (Figure 2.4B). The peptide is anchored in the active site of the enzyme through several
hydrogen bonds. Y38 and Y165, both of which are conserved between Naa50 and Naa60, form
hydrogen bonds to the carbonyl groups of M1p and K2p respectively, while the backbone carbonyl
of L99 forms a hydrogen bond to the backbone amide of M1p (Figure 2.4C).
There are also major differences between these enzymes. While the Naa50
structure

reveals

a

second

hydrophobic pocket for residue 2p, the corresponding region of

Naa60 is more solvent exposed and thus can accommodate more variability in position 2p
(Figures 2.4D–2.4F). Indeed, K2p of the MKAV7 peptide region of the CoA-Ac-MKAV7
bisubstrate inhibitor, as well as A3p and V4p side chains, do not make significant interactions to
the protein. The larger and more solvent-exposed cavity of Naa60 suggest that this enzyme is able
to accommodate larger and more polar residues at positions 2p and 3p compared with Naa50,
which previously has been shown to prefer methionine-starting substrates with hydrophobic
amino acids such as leucine or valine in position 2p. An interesting feature of the binding pocket
is the presence of E70 in β3 (Figure 2.4D). This replaces a bulkier basic residue that is found in
all of the other NATS at this position (Figure 2.4D and Figure 2.1), and it likely contributes to the
ability of Naa60 to more efficiently acetylate peptides with lysine in the second position than the
other NATs.

2.2.3 Mutational analysis of Naa60 shows good correlation with the structure
In order to examine the importance of specific residues on the catalytic and substrate
binding function of Naa60, several Naa60 point mutants were created and tested for activity using
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the substrate peptide MKAV24 peptide substrates, representing a substrate that previously was
shown to be acetylated by Naa60 in vivo (Van Damme, Hole, et al. 2011a; Aksnes, Van Damme,
Goris, Starheim, Marie, Stove, et al. 2015). Mutation of residues directly involved in the catalysis
of Naa60 resulted in severe impairments. An Y97F point mutant showed complete loss of
catalytic activity (Figure 2.5) confirming that this residue is important for Naa60 catalysis.
Interestingly, H138F and H138A mutants turned out to be very unstable and difficult to purify,
suggesting that this residue not only is involved in catalysis, but that it also is important for
maintaining the overall structure of Naa60.
We also prepared several point mutants of residues that form the hydrophobic pocket
surrounding the M1p side chain. P35A, I36A, and I167A all showed an approximate 2.5- to 4-fold
reduction in kcat and a small increase in KM when tested toward the substrate polypeptide
MKAV24 (Figure 2.5A). Surprisingly, the Naa60 L140A mutant had a 4- to 5-fold increase in kcat
but at the same time a 5- to 10-fold increase in KM (Figure 2.5A). Thus, despite the increased kcat,
the catalytic efficiency (kcat/KM) of this mutant is approximately 0.5-fold of Naa60 wild-type
(WT) (Table 2.2). In comparison, the catalytic efficiency of the P35A, I36A, and I167A point
mutants had approximately 6-fold, 6-fold, and 3-fold reduction compared with the Naa60 WT,
respectively (Table 2.2). We also created a P35A/I36A/I167A triple mutant, but were unable to
detect any catalytic activity for this mutant in our assay (Table 2.2). Together, these data show
that the M1p hydrophobic pocket is important for substrate-specific acetylation.
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Figure 15 Catalytic Parameters of Naa60 WT and Mutants:
(A) kcat values (black bars) and KM values (yellow bars) of wild-type Naa60 and selected Naa60
mutants toward the substrate polypeptide MKAV24. (B) Catalytic efficiency of Naa60 (black bars)
and Naa50 (blue bars) toward different substrate polypeptides representing previously identified
Naa60 or Naa50 substrates in vivo. All experiments were performed in triplicate and data are
represented as means ± SEM.
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Table 2.2 Catalytic Efficiency of Naa60 WT and mutants
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To probe the importance of substrate polypeptide anchoring in the active site, we
mutated tyrosines Y38 and Y165 that showed hydrogen bonds with the peptide substrate
backbone (Figure 2.4C). Y165 also forms parts of the hydrophobic pocket surrounding the sidechain peptide substrate M1p; however, by creating a Y165F point mutant only the hydroxyl
group involved in peptide anchoring will be removed and the hydrophobic pocket will remain
unaffected. The Naa60 Y38A variant resulted in a complete loss of catalytic activity, while the
Naa60 Y165F mutant had an approximately 4-fold reduction in catalytic efficiency (Table 2.2).
Together, these studies show that Y38 and Y165 play important roles in peptide binding.
To probe the substrate selectivity of Naa60 for comparison with Naa50, we determined
kinetic constants for both Naa60 and Naa50 toward several different peptides representing Ntermini that were previously identified as substrates of either Naa60 or Naa50 in vivo (Van
Damme, Hole, et al. 2011b; Aksnes, Van Damme, Goris, Starheim, Marie, Støve, et al. 2015).
The catalytic efficiency of the two enzymes is similar for several of the tested substrates, but
there are also differences (Figure 2.5B). As expected, Naa50 has the highest catalytic efficiency
for the substrate polypeptides MLGP24 and MVSM24. Naa60, on the other hand, has the highest
catalytic efficiency for peptide substrates MAPL24, MVSM24, MKAV24, and MKQY24.
Interestingly, while Naa60 had approximately the same catalytic efficiency for MKAV24 and
MKQY24 with larger more bulky side chains in position 3p and 4p, Naa50 had a 3-fold lower
catalytic efficiency for MKQY24 compared with MKAV24. This is consistent with the larger and
more solvent-exposed cavity seen in Naa60 relative to Naa50 around the K2p, A3p, and
V4p residues of the bisubstrate analog.
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2.2.4 The Naa60 specific β3-β4 loop plays a role in protein stability
The elongated 22-residue β3-β4 loop (residues 73-94) is a structure not found in most
NATs. In Naa10 and Naa50, β3 and β4 are linked together with only a short beta hairpin. In
contrast, in both ssNAT and Naa60, β3 and β4 are linked together by a large elongated loop, with
the loop being significantly larger inNaa60 (Figure 2.6A). The β3-β4 loop of Naa60 folds back
towards the enzyme core and peptide portion of the bisubstrate inhibitor to make multiple
hydrogen bonds and van der Waals contacts to residues in β-strands 5, 6 and 7 (Figure 2.6A).
D81 and D83 of the β3-β4 loop make hydrogen bonds to H138 and H157 of the β5 and β7 strands
respectively (Figure 2.6B) and the backbone amide nitrogen of I77 makes a water mediated
hydrogen bond to the phenol oxygen of Y136 (not shown). In addition E80, D81 and the
backbone carbonyl of I84 forms a hydrogen bonds with Y164, T176 and Y180 of the β6 strand
respectively (Figure 2.6B). Several residues of the β3-β4 loop (I77, I84, L85) also participate in
van der Waals interactions with residues of the β5-β6-β7 core (Y136, V178, Tyr180) (Figure S4).
Interestingly, despite the large number of contacts between the β3-β4 loop and β5, β6 and β7
strands, mutational analysis suggest that the positioning of this loop is easily disrupted. Mutating
some of the residues that forms these contacts (D81A, D83A or Y164A/F) all result in a 3-6 fold
increase in kcat, but also a 2-4 fold increase in the KM of the reaction (Figures 2.5A and 2.5B),
resulting in a modest overall effect on catalytic efficiency (Table 2). This could indicate that
mutating residues involved in the contact between the β3-β4 loop and β5, β6 and β7 strands is
altering the structure of the enzyme in a way that only affects substrate peptide binding and
catalysis in subtle ways.
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Figure 16 The Naa60-Specific β3-β4 Loop
(A) Residues D81 and D83 (pink sticks) of the extended β3-β4 loop of Naa60 (shown in pink)
that form salt bridges with residues H138 and H159 (yellow sticks) of β5 and β7 are shown. E80
and D81 (pink sticks) that form hydrogen bonds with Y164 and T176 (yellow sticks) of β6 and
the carbonyl backbone of I84 (pink sticks) that form a hydrogen bond with Y180 (yellow sticks)
are also shown. The CoA-Ac-MKAV is shown as green sticks. (B) Residues I77, I84, and L85
(pink sticks) that form a hydrophobic interior of the loop and participate in van der Waals
interactions with residues V95, A134, Y136, and V178 (yellow sticks) of β5, β6, and β7 strands is
shown.
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To further investigate the effects of mutating these residues, we analyzed the stability of
these point mutants by differential scanning fluorimetry as has been described previously
(Figure 2.7) (Bustad et al., 2012). Apo Naa60 WT had a melting point of 47.9 °C and was clearly
stabilized both by the addition of Ac-CoA (Tm increased gradually from 48 °C to 54.7 °C by
addition of 0.16x–10x Ac-CoA) and the bisubstrate analog CoA-Ac-MAPL7 (Tm ranging from
47.6 °C–53.2 °C with increasing bisubstrate analog concentrations) (Figures 2.7A and 2.7B). As
expected, the I36A point mutant that had severe catalytic effects due to disruption of the M1p
hydrophobic pocket did not show any signs of destabilization, while Naa60 mutants involved in
forming contacts between the β3-β4 loop and β5, β6 and β7 strands, D81A, I84A, and Y164F,
were all clearly destabilized compared with Naa60 WT (Figures 2.7C–2.7F). Furthermore, a
higher initial fluorescence was seen for both Naa60 D81A and I84A, indicating that more
hydrophobic areas are exposed to the solvent, most likely due to a destabilized β3-β4 loop.
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Figure 17 Thermal stability of wild-type Naa60 and mutants
DSF- monitored thermal denaturation of wild-type Naa60 and mutants. Enzymes were mixed
with SYPRO Orange and either CoA or CoA-Ac-MAPL7 at a molar ratio varying from 0.16:1 –
10:1, and the stability was measured at temperatures increasing from 22 to 95°C. (A) Thermal
denaturation of Apo wild type Naa60 and wild-type Naa60 in the presence of increasing
concentration of Ac- CoA. (B) Thermal denaturation of Apo wild-type Naa60 and wild-type
Naa60 in the presence of increasing concentration of the bisubstrate analogue CoA-Ac-MAPL7.
(C) – (F) Thermal denaturation of Apo Naa60 mutants I36A, D81A, I84A and Y164F and Naa60
mutants I36A, D81A, I84A and Y164F respectively in the presence of increasing concentration of
Ac-CoA.
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2.2.5 Naa60 dimerizes through the Naa60-specific β6-β7 loop in the absence of substrate peptide.
In order to determine if Naa60 undergoes any structural changes upon N-terminal peptide
substrate binding, we determined the crystal structure of the Naa60/CoA complex. We obtained
crystals that formed in the P21 space group and determined the structure by molecular
replacement using the protein portion of ssNAT (PDB: 4LX9) as a search model. The crystals
contained four Naa60/CoA complexes per asymmetric unit cell and refined to an Rwork/Rfree of
0.2072/0.2547 with good geometry at 1.95 Å resolution (Table 2.1). Interestingly, in contrast to
the monomeric Naa60/CoA-Ac-MKAV7 complex, the Naa60/CoA structures shows two
symmetrical protein dimers, where dimer interactions are nucleated by the β6-β7 loops that form
a four stranded sheet that extends into the peptide-binding sites of both subunits of the dimer
(Figures 2.8A). A superposition of the Naa60/CoA-Ac-MKAV7 complex with a subunit of the
Naa60/CoA complex shows that the only significant structural change is a rotation of the β6-β7
loop in the Naa60/CoA-Ac-MKAV7 out by about 45° to accommodate the insertion of the β6-β7
loop from the opposing subunit of the Naa60/CoA dimer (Figure 2.8B). The superimposition also
reveals that the Naa60 homodimer is incompatible with peptide binding by Naa60. Specifically,
the β6-β7 loop of the first protomer protrudes into the catalytic site of the second protomer of the
dimer, leaving no room for a substrate peptide to bind.
Numerous contacts mediate Naa60/CoA homodimerization, several of which participate
in peptide substrate anchoring in the Naa60 monomer (Figure 2.8D). L171 from each subunit
make van der Waals contacts across the dimer. van der Waals contacts are also mediated between
Y165 and Y38b and P39b of the core (b designates the second protomer of the dimer), and I167
and V170 with L140b and I36b of the core, respectively. In addition, I36b of the core makes van
der Waals interactions with the main chain of the β hairpin formed by residues S166, I167, R168,
and G169. R168 also hydrogen bonds to the main-chain carbonyls of P162b and K172b of the
core. Many of the residues in the β6-β7 loop that interact with the opposing subunit are specific
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for Naa60 (Figure 2.1) and no other NAT structure determined to date shows this type of
homodimerization.
To investigate whether Naa60 dimers are formed in solution, we performed sizeexclusion chromatography and analytic ultracentrifugation (AUC). On a size exclusion
chromatography column, Naa60 (1-184) with AcCoA elutes at a column volume corresponding to
twice the theoretical size of the enzyme (Figure 2.8F). However, upon addition of 2 equivalents
of the bisubstrate analogue CoA-Ac-MAPL7, more than 50% of the enzymes elutes as an
apparent monomer from a size exclusion chromatography column. To further corroborate these
findings, we performed AUC on the fractions of Naa60 bound to AcCoA that eluted off the size
exclusion column in an apparent dimer peak (Figure 2.8F), and on the fractions of Naa60 bound
to CoA-Ac-MAPL7 which eluted as an apparent monomer peak (Figure 2.8G). We performed the
centrifugation at three different speeds and three different concentrations. The data fit extremely
well to a Naa60/CoA-Ac-MAPL7 monomer with a molecular weight of 22.9 kD, and a Naa60/
CoA dimer with a molecular weight of 39.9 kD, which are very close to the theoretical molecular
weights of 22.6 kD and 43.6 kD, respectively. These data support the peptide substrate-dependent
dimer to monomer transition of Naa60 suggested by the crystal structures.
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Figure 18 Naa60 dimerization (from previous page)
(A) Crystal structure of the Naa60-CoA homodimer complex. CoA is shown as green sticks. (B)
Superimposition of the β6-β7 loop in a monomeric state (shown in yellow) and in a dimeric state
(shown in red). (C) Superimposition of the Naa60/CoA-Ac-MKAV7 structure (only showing
CoA-Ac-MKAV7) with the Naa60/CoA dimer. (D) Contacts between the two Naa60 protomers.
The side chain of K172b was omitted for clarity. (E) Size-exclusion chromatography of Naa60(1–
184) mixed with either 2× or 10× excess of Ac-CoA or 0.5×, 2×, or 10× excess of the bisubstrate
analog CoA-Ac-MAPL7. The first peak corresponds to an Naa60 homodimer and the second peak
to an Naa60 monomer. (F) Sedimentation equilibrium analytical ultracentrifugation experiments
of Naa60 mixed with the bisubstrate analog CoA-Ac-MAPL7, which eluted as a dimer. RMS,
root-mean-square. (G) Sedimentation equilibrium analytical ultracentrifugation experiments of
Naa60 mixed with the bisubstrate analog CoA-Ac-MAPL7, which eluted as a monomer.
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2.3 Discussion
In this study, we have crystallized and biochemically characterized Naa60, the only
human NAT identified so far with distinct organellar localization, and the only NAT identified
that primarily acetylates membrane proteins. As previously shown in vivo, Naa60 has an
organellar localization that is dependent on the C-terminal 60 amino acids (residues 182-242)
(Aksnes, Van Damme, Goris, Starheim, Marie, Stove, et al. 2015). The present study reveals that
Naa60 1-184 forms a GNAT fold that highly resembles the Naa50 structure. Our studies also
show that the C-terminus of Naa60 is not necessary for its biochemical function. Indeed,
subsequent experiments have shown that the C-terminus of Naa60 forms two alpha helices, which
facilitates the peripheral anchoring of Naa60 to the membrane via interaction with ionic lipids
(Aksnes, Van Damme, Goris, Starheim, Marie, Stove, et al. 2015; Aksnes et al. 2017).
To study the molecular basis for substrate-specific acetylation by Naa60, we designed
and synthesized two bisubstrate analogs, one of which was co-crystallized with Naa60. This
approach was chosen as a result of difficulties in obtaining a crystal structure of a
Naa60/CoA/peptide ternary complex. A similar approach was previously used in the
crystallization of the p300/CBP transcriptional co-activator (Liu et al. 2008), using a bisubstrate
analog with CoA attached to the side chain of lysine, which both facilitated crystallization of this
enzyme and enabled investigation of substrate-enzyme interactions and mechanisms. Bisubstrate
analogs have also been successfully used as enzyme-specific and potent NAT inhibitors (Foyn et
al. 2013), and were also used to crystallize and study the NatA complex (Liszczak et al. 2013).
The bisubstrate analogs presented here represent the first Naa60-specific bisubstrate analogs and
the second case whereby such analogs have been used as a tool for the investigation of amino
acid substrate interactions in NAT enzymes.
The overall structure of Naa60 aligns very well with other available NAT structures and
is very similar to the overall structure of Naa50 (RMSD=1.59 Å). Of particular interest to us was
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the active site of Naa60, and whether there were any differences in its substrate peptide binding
and catalytic mechanism compared with Naa50 and other NATs. Our data reveal that Naa60
utilizes the same catalytic mechanism as Naa50, and that all residues directly associated with
catalysis are conserved between the two enzymes. Substrate peptide anchoring is also highly
conserved, in addition to key residues involved in forming a hydrophobic pocket surrounding the
M1 side chain of the substrate peptide. However, there are notable differences. In Naa50, a
second hydrophobic pocket is formed around substrate peptide residue 2p, enabling Naa50 to
efficiently acetylate substrates with a methionine in position 1p followed by a hydrophobic
residue in position 2p. In comparison, the corresponding region of Naa60 is more solvent exposed
and has more room for substrates with larger charged side chains. Whether Naa60 evolved to
acetylate many, or some of these substrates compared to the other NATs remains to be
determined.
Despite the large overall structural similarity between Naa50 and Naa60, there are several
features that are specific for Naa60. A prominent difference maps to the β3-β4 loop, which is
extended by 10–15 residues in Naa60 compared with the other NATs. The elongated loop
interacts with residues in β-strands β5, β6, and β7, and point mutation of key residues in this loop
resulted in a slightly increased catalytic efficiency of the enzyme. The exact function of this loop
is still unclear, and interestingly, we show that loss of the interaction between the β3-β4 loop and
β-strands β5, β6, and β7 not only results in altered acetyltransferase activity, but also cause a
substantial drop in protein stability with a melting point that is 5°C–10°C lower than for WT
Naa60.
A second structural feature that is unique to Naa60 is the elongated β6-β7 loop. Sequence
alignments of Naa60 and NAT-homologues show that the loop is extended by 3-5 residues
(Figure 2.1). Interestingly these residues mediate dimerization of Naa60 in the absence of
substrate peptide, a feature that to our knowledge has never been seen for any other NAT. The
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β6-β7 loop of each monomer extends into the peptide-binding site of the second subunit of the
dimer and is stabilized by hydrogen bond and van der Waals interactions. As the Naa60
dimerization is mediated by the β6-β7 loop of both monomers extending into the active site of
each other, it seems very unlikely that Naa60 can be catalytically active in its dimeric form.
However, our size exclusion chromatography and AUC data also shows that Naa60 can
dynamically shift between a monomeric and dimeric state. This is also reflected in enzymatic
assays; although Naa60 is purified as a homodimer, this dimer is catalytically active. The
substrate peptide therefore likely competes with the β6-β7 loop of the other Naa60 subunit for
binding in the active site. This could be a way to regulate substrate-specificity, as the affinity for
a potential substrate may have to be higher than the affinity for the other subunit of the monomer.
In vivo, Naa60 is not freely diffusible through the cytoplasm, but rather specifically associates
with the Golgi membrane through the C-terminus (Aksnes et al. 2017). These membrane
interactions may therefore also contribute to formation of the Naa60 dimer in the absence of
peptide substrate. Consistent with this model, in the Naa60 homodimer the C-terminal end of both
Naa60 1-184 monomers are pointing in the same direction, supporting that dimerization is
compatible with Naa60 attachment to organellar membranes (Figure 2.9).
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Figure 19 Schematic illustration of the potential positioning of the Naa60 homodimer
relative to organellar membranes
Naa60 is known to associate with Golgi membranes through its C-terminus. In the structure of the
Naa60 homodimer, both C-termini are pointing in the same direction, suggesting that Naa60
homodimerization also can occur in vivo at the Golgi. Note the position of the β3-β4 loop in this
model is close to the membrane, suggesting a role for aiding localization or substrate interaction.
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The majority of proteins that are N-terminally acetylated are modified co-translationally
as they emerge from the ribosomal exit tunnel, and several NATs have previously been shown to
associate with the ribosome As Naa60 was shown to localize to the cytosolic side of Golgi
membranes, and as the bulk of all detected Naa60 is associated with membranes, it is likely that
Naa60 does not directly associate with ribosomes but rather acts post-translationally, acetylating
transmembrane proteins with N-termini facing the cytosol. What role the unique β3-β4, and β6β7 loops have on the in vivo substrate profile of Naa60 remain to be determined.

2.4 Materials and methods
2.4.1 Naa60 cloning, expression and protein purification
A C-terminal truncation construct coding for His-SUMO-Naa60(1–184) was expressed in
Rosetta (DE3) pLys competent cells overnight at 17°C. Cells were lysed in lysis buffer (25 mM
Tris-HCl [pH 8.0], 1 M NaCl, 10 mM β-mercaptoethanol, and 10 µg/ml PMSF) by sonication, the
cell lysate was centrifuged at 17,000 × g for 30 min, and overexpressed His-tagged proteins were
isolated by passing the supernatant over nickel resin. The resin was washed with wash buffer
(25 mM Tris-HCl [pH 8.0], 250 mM NaCl, 20 mM imidazole, 10 mM β-mercaptoethanol) and
bound proteins eluted by slowly increasing the imidazole concentration to 300 mM. The HisSUMO tag was cleaved by adding SUMO protease (Ulp-1) to the eluted protein while the protein
was dialyzed into a buffer without imidazole (25 mM Tris-HCl [pH 8.0], 250 mM NaCl, and
10 mM β-mercaptoethanol), and the tag was removed from the sample by reverse nickel
purification. The flow-through was collected and dialyzed into size-exclusion buffer (25 mM
HEPES [pH 7.5], 300 mM NaCl, and 1 mM DTT). The dialyzed sample was concentrated to a
final volume of 1 ml and loaded on a HiLoad Superdex 200 size-exclusion chromatography
column. Fractions containing Naa60 (1–184) were collected and used for protein crystallization.
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2.4.2 Synthesis of bisubstrate analogues
As previously reported, bisubstrate analogues can be very potent inhibitors (Foyn et al.
2013). Based on the substrate specificity profile determined by Naa60 knock-down and
overexpression followed by proteomics (Aksnes, Van Damme, Goris, Starheim, Marie, Stove, et
al. 2015; Van Damme, Hole, et al. 2011a), we selected two polypeptide sequences from known
Naa60 substrates and used the peptide sequence of the 7 first residues as a template for Naa60
bisubstrate analogues. The bisubstrate analogues were synthesized as described previously (Foyn
et al. 2013). Briefly, peptides were synthesized by automated solid phase peptide synthesis using
the Fmoc strategy. Amino acids were coupled to Knorr amide MBHA resin on the 0.2 mmol scale
and synthesized peptides were treated with bromoacetic acid in the presence of
diisopropylcarbodiimide before the peptides were cleaved from the resin with trifluoroacetic acid
(TFA):triisopropylsilane:ddH2O (95:2.5:2.5). Peptides were precipitated, purified by reversephase high performance liquid chromatography, lypholized and Coenzyme A (CoA) was attached
by reacting bromoacetylated peptide with two eq. CoA in triethylammonium bicarbonate buffer
pH 8.0. Synthesized compounds were purified to a typical purity of >95% by RP-HPLC, verified
by MALDI-MS and lyophilized.

2.4.3 Crystallization and data collection
The Naa60/CoA structure was obtained by mixing 18 mg/ml purified Naa60 (1-184) with
1:3:5 molar ratio of Naa60:CoA:MAPL7 peptide (although electron density corresponding to the
MAPL7 peptide was not observed in the final structure). Crystals were obtained by hanging-drop
vapor diffusion at 20˚C for 1-3 days against a reservoir solution of 3% Tascimate, 0.1 M Bis-Tris
pH 6.5 and 16% PEG 3350. For the Naa60/CoA-Ac-MKAV7 bisubstrate analog structure, the Nand C-terminal truncation variant Naa60 (5–184) was purified, concentrated to 13 mg/ml, and
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mixed with the bisubstrate analog CoA-Ac-MKAV7 at a 1:3 molar ratio. Crystals were obtained
by hanging-drop vapor diffusion at 20 ˚C over 3 months against a reservoir solution of 4%
Tacsimate (pH 4.0) and 12% PEG 3500. Naa60/CoA crystals were transferred to a series of
cryoprotectant solutions containing well solution supplemented with 300 mM NaCl and 5%, 10%,
and 25% glycerol prior to flash-freezing in liquid nitrogen. Naa60/CoA-Ac-MKAV7 crystals were
transferred into a cryoprotectant containing its reservoir solution supplemented with 20%
glycerol. Both datasets were collected at beamline X29A at the National Synchrotron Light
source (Brookhaven National Laboratory) and were processed using HKL2000 (Otwinowski and
Minor 1997).

2.4.4 Structure determination and refinement
The binary Naa60/CoA complex was determined by molecular replacement using a
structure of ssNAT prepared with CHAINSAW (Stein 2008) without solvent molecules or
cofactors as a search model. Molecular replacement was performed with Phaser in the CCP4
suite. Initial rounds of manual model building were performed with Coot (Emsley and Cowtan
2004), and all subsequent rounds of refinement were performed using Phenix refine and Coot
interchangeably. The binary Naa60/CoA-Ac-MKAV7 complex was determined by molecular
replacement using the binary Naa60/CoA complex as a search model and refined essentially as
described above. For both binary complexes, the cofactor/bisubstrate analogue was built into F0 Fc electron density maps. Refinement statistics are shown in Table 1.

57

2.4.5 In Vitro Acetylation Assays
A colorimetric acetylation assay (Thompson et al. 2004) was used to measure the
catalytic activity of Naa60 variants. Purified enzymes were mixed with substrate peptides and AcCoA in acetylation buffer (50 mM HEPES [pH 7.5], 100 mM NaCl, and 2 mM EDTA), and
reactions were quenched with quenching buffer (3.2 M guanidinium-HCl and 100 mM sodium
phosphate dibasic [pH 6.8]). For measurement of CoA production, 5,5′-dithio-bis-(2-nitrobenzoic
acid) (2 mM final, dissolved in 100 mM sodium phosphate dibasic [pH 6.8] and 10 mM EDTA)
was added to the quenched reaction, and the absorbance at 412 nm was measured. Background
absorbance was determined in negative controls and subtracted from the absorbance determined
in each individual reaction. Thiophenolate production was quantified assuming ɛ = 13.7 ×
103 M−1 cm−1. Product formation was measured in the linear phase of the reaction, and kinetic
constants were determined by GraphPad Prism. In the quantitative acetylation assay the following
oligopeptides (synthesized by Biogenes) were used:
MKAV24: MKAVQADRWGRPVGRRRRPVRVYP
MAPL24: MAPLDLDRWGRPVGRRRRPVRVYP
MKQY24: MKQYQGSRWGRPVGRRRRPVRVYP
MVM24: MVSMSFKRWGRPVGRRRRPVRVYP
MLGP24: MLGPEGGRWGRPVGRRRRPVRVYP

2.4.6 Determination of IC50 values
Purified SUMO-Naa60 1-184 (500 nM) was mixed with MAPL24 substrate peptide (300
mM), acetyl-CoA (300 mM) and inhibitor (0-15 mM) or desulfoCoA (0-400 mM) in a total of 50
mL at 37°C for 45 min. IC50 values were determined by fitting the data using Grafit 7 and the
equation activity(%) = 100%/(1+([I]/IC50)s), where [I] is the concentration of inhibitor and s is a
slope factor (Hill coefficient).
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2.4.7 Differential scanning fluoremetry (DSF)
Purified wild-type Naa60 and mutants were diluted to a final concentration of 0.1 mg/mL
in a 25 mM HEPES (pH 7.5) buffer containing 300 mM NaCl and 1 mM DTT. Enzymes were
mixed with 5x SYPRO Orange and added to a 1:2 dilution series of either Ac- CoA or the CoAAc-MAPL7 bisubstrate analogue. Thermal denaturation was studied in 8 different conditions;
enzyme without any cofactor and enzyme in 7 different concentrations of CoA or CoA-AcMAPL7. Samples were heated from 22 to 95°C at a scan rate of 2°C/min and fluorescence was
quantified with a data pitch of 0.2°C on a LightCycler 480 Real-Time PCR System from Roche
Applied Science (F. Hoffmann–La Roche Ltd., Basel, Switzerland).

2.4.8 Analytical Ultracentrifugation
Sedimentation equilibrium analytical ultracentrifugation experiments were performed at 4
°C with absorbance optics at 280 nm using a Beckman Optima XL-I analytical ultracentrifuge.
We employed the use of a 4-hole rotor containing six-channel centerpieces with quartz windows,
spinning at 6000, 18000 and 26000 rpm. Naa60 was mixed with a five molar excess of either
acetyl-CoA or CoA-Ac-MKAV7 and run on a superdex 75 gel filtration column. Protein samples
were analyzed at A280 = 0.7, 0.5, and 0.3 in gel filtration buffer (25 mM HEPES pH 7.5, 300 mM
NaCl, 1 mM DTT). Data for each speed were collected in quadruplicate. The viscosity of the
samples were estimated using Sedenterp (http://sednterp.unh.edu/) and the most representative
runs were included to calculate a theoretical molecular weight using the program HeteroAnalysis
(http://www.biotech.uconn.edu/auf/?i=aufftp)
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CHAPTER 3: The Molecular Basis for Histone H4- and H2A-Specific Amino-Terminal
Acetylation by NatD

This work was originally published in Structure (Magin, Liszczak, and Marmorstein 2015b) ©
Cell Press
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3.1 Introduction
NatD (also known as Nat4, Naa40, or Patt1) activity was first observed in the yeast S.
cerevisiae when a NatA yeast knockout strain was noted to harbor N-terminal acetylated histones
H2A and H4, which contain an N-terminal serine residue that is typically N-terminally acetylated
by NatA (Mullen et al. 1989). NatD from S. cerevisiae was subsequently cloned (Song et al.
2003), and the human homolog was later characterized (Hole et al. 2011). The only NatD
substrates known to date are histones H2A and H4, making it the most substrate selective NAT
enzyme so far characterized. The biological role of N-terminal H4 acetylation has only recently
come to light. Schiza et al demonstrated that the presence of an N-terminal acetyl group on H4
downregulates asymmetric dimethylation on H4 Arg-3 by the Hmt1 arginine methyltransferase.
(Schiza et al. 2013). The absence of asymmetric Arg-3 methylation in turn negatively regulates
ribosomal DNA transcription. In this way, the presence of an acetyl group on H4 could act as a
sensor for cell growth. NatD has also been implicated in disease. NatD is downregulated in
hepatocellular carcinoma, and overexpression of NatD in the cancerous cells enhances apoptosis
(Liu et al. 2009). NatD liver-specific knockout male mice have decreased body mass and are
protected from age-associated hepatic steatosis (Liu et al. 2012).
In this study, we set out to understand the molecular basis for H4 and H2A specific
acetylation by NatD. To do so, we crystallized NatD in binary complex with acetyl-CoA, and in
ternary complex with CoA and an N-terminal histone H4/H2A substrate peptide, and performed
biochemical and enzymatic characterization of the enzyme. A novel N-terminal segment wraps
around the catalytic core domain to make stabilizing interactions, and the α1-α2 and β6-β7 loop
adopt novel conformations to properly orient the histone N-termini in the binding site. Ser1 and
Arg3 sit in complementary substrate binding pockets to make extensive contacts to highly
conserved and mutationally sensitive NatD residues, and flanking glycine resides appear to
contribute to substrate-specific binding by NatD, together defining a Ser-Gly-Arg-Gly
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recognition sequence. These studies have implications for understanding substrate-specific
acetylation by the broader family of NAT enzymes.

3.2 Results
3.2.1 Overall structure of NatD
An alignment of NatD sequences from various organisms reveals a ~150 residue region
(residues 55-216 in human) of high sequence conservation, which we hypothesized mapped to the
acetyltransferase domain (Figure 3.1). In order to prepare recombinant NatD protein variants for
biochemical and structural studies, we bacterially overexpressed several NatD protein variants
derived from S. pombe or human. This led to the identification of S. pombe NatD (SpNatD,
residues 13-204) and human NatD (hNatD, residues 17-220) that formed cocrystals with
substrate(s) suitable of X-ray structure determinations. Crystals were prepared of SpNatD and
hNatD in the presence of acetyl-CoA, and of hNatD in the presence of CoA and an N-terminal
histone H4/H2A pentapeptide (SGRGK). Selenomethionine-labeled SpNatD was prepared to
determine the SpNatD/Ac-CoA structure using single-wavelength anomalous diffraction, and this
structure was used to determine the hNatD/Ac-CoA and hNatD/CoA/peptide structures using
molecular replacement. The structures were refined to high quality and to medium/high resolution
(Table 3.1). The overall SpNatD and hNatD structures are essentially superimposable, with an
RMSD of 1.08 Å (Figure 3.2A). The remainder of this manuscript will describe the human NatD
structures, NatD/Ac-CoA (Resolution=1.78 Å, Rfree/Rwork=20.6%/16.9%) and NatD/CoA/peptide
(Resolution=2.5 Å (Rfree/Rwork=22.3/17.5).
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Figure 3.1 Sequence alignment of NatD orthologs
The sequence alignment contains the following NatD orthologs: human (Homo sapiens), fission
yeast (Schizosaccharomyces pombe), fruit fly (Drosophila melanogaster), spikemoss (Selaginella
moellendorffii), and sea anemone (Nematostella vectensis). The blue boxes represent conserved
patches of sequence alignment. Residues in red are highly conserved, and residues in white with a
red background are strictly conserved. Above the sequence alignment are indicated amino acid
numbering for H. sapiens and secondary structure elements. Amino acid residues are indicated
that make contacts to the substrate peptide (●), show mutational sensitivity (+), or are proposed to
play catalytic roles (*).
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Table 3.1 Data Statistics for NatD crystal structures
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Figure 3.2 Overall structure of NatD complexes
(A) Superposition of the SpNatD/acetyl-CoA (violet), hNatD/acetyl-CoA (brown), and
hNatD/CoA/H4-H2A peptide (cyan) complexes. CoA is shown as sticks, and the H4-H2A peptide
is omitted for clarity. (B) Overall structure of hNatD/CoA/H4-H2A peptide with structurally
unique elements of NatD relative to other NATs highlighted in yellow. CoA is shown in orange
and H4 is shown in magenta.
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The overall NatD structure has a mixed alpha/beta GCN5-like fold (Figure 3.2B) similar
to the other reported NAT structures (Liszczak, Arnesen, and Marmorstein 2011; Liszczak et al.
2013; Liszczak and Marmorstein 2013). However, there are notable differences between NatD
and the other solved NAT structures, NatA and NatE (Figure 3.3A). In particular, differences are
noted in the loops forming the peptide-binding site, and that NatD contains a unique N-terminal
segment.
A striking divergent feature of NatD is its loops flanking the substrate binding site, β6β7 and α1-α2. A characteristic feature of the peptide-binding site of the NAT proteins is that these
loops appear to be used to prevent internal lysines from inserting into the active site. This is in
contrast to the more open loop configuration of lysine acetyltransferases such as Gcn5 (Rojas et
al. 1999) and Hat1 (Li et al. 2014). In the case of NatA and NatE, a β6-β7 hairpin loop serves this
function. In NatD, the corresponding β6-β7 hairpin loop is flipped away from the substratebinding site and instead the binding pocket is blocked by an extended α1-α2 loop on the opposite
side (Figure 3.3B). As will be discussed below, this difference appears to be critically important
for substrate-specific binding by NatD.
The novel NatD N-terminal segment (residues 24-51) adopts a helix-loop-strand topology
that wraps around the catalytic core domain, making complementary interactions with a
hydrophobic patch that appears to be important for stability of the protein (Figure 3.3C). The
interface between the N-terminal segment and a cleft on a surface of the catalytic core domain is
largely hydrophobic. Specifically, residues Pro-38, Leu-39, Phe-42, Phe-45, Tyr-48 of the Nterminal segment make Van der Waals contacts to residues Leu-53, Ile-57, Cys-59, Trp-107, Leu109, Phe-124, Phe-126, Leu-151, Phe-154, Ile-158, Leu-161, and Met-162 of the core domain
(Figure 3.3D). Consistent with the importance of these contacts for stability of the catalytic core
domain, N-terminally truncated proteins beginning at residue 47 were not stable through
purification, yet constructs beginning at residue 37 were (data not shown). The region from
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residues 37-48 contains the key hydrophobic residues that interact with the hydrophobic surface
cleft of the core domain. Notably, the residues that line this hydrophobic cleft are replaced with
more hydrophilic residues in the other NAT proteins, which would explain why they lack the
extended N-terminus. We have designated the alpha helix and beta strand in this novel N-terminal
region α0 and β0, respectively, in order to keep secondary structure nomenclature consistent with
the other NAT proteins (Liszczak and Marmorstein 2013; Liszczak et al. 2013; Liszczak,
Arnesen, and Marmorstein 2011).
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Figure 3.3 Unique structural features of NatD
(A) Superposition of hNatD (cyan), SpNatA (orange), and hNatE (green) complexes. The H4H2A peptide is shown in magenta. Only the CoA from the hNatD/CoA/H4-H2A peptide structure
is shown for clarity. (B) Close-up view of the substrate binding groove of NatD in comparison
with NatA and NatE. The color coding is as in Figure 3.3A. NatA substrate (SASE) and NatE
substrate (MLGP) are shown as orange and green sticks, respectively. (C) View of the interaction
of the NatD N-terminal segment (yellow cartoon representation) with the catalytic core domain
(cyan surface representation). (D) Detailed interactions between the N-terminal segment and
catalytic core domain of NatD. Residues from the N terminus that mediate interactions are
labeled in black, and residues from the core domain are colored in dark blue and labeled in white.
Met-162 is omitted for clarity.
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3.2.2 Substrate recognition by NatD
The structure of NatD in complex with CoA and the N-terminus of histones H4/H2A
provides important insights into substrate binding. The overall structure of the protein from the
ternary complex is very similar to the binary complex, with an RMSD of 0.313 Å. The density for
the peptide is well defined, and we were able to unambiguously place all atoms expect for the
Lys5p side chain. The binding pocket for the peptide is highly acidic, which is in line with the
basicity of the histone tails (Figure 3.4A). The ternary complex reveals extensive interactions
with the substrate peptide and NatD (Figure 3.4B). Notably, contacts occur along the entire length
of the peptide; each amide nitrogen and oxygen is hydrogen bonded except for the Arg3p amide
oxygen. There are direct hydrogen bonds to the backbone amide groups on the peptide from
residues Tyr-138, Thr-174, Ser-197 and Tyr-211 of NatD. In addition, there are water-mediated
contacts between residues Glu-100, Tyr-136, and Thr-174 to the backbone amides of the peptide.
The aliphatic region of Trp-90 interacts with Gly2p and Gly4p of the peptide via van der Waals
contacts. Ile-213 makes van der Waals contacts with the backbone of Lys5p.
The residues along the peptide path are poised to confer specificity for recognition by the
enzyme. Ser1p sits in a pocket which would not accommodate residues with larger side chains, as
they would be occluded by Met-81, Tyr-85, and Glu-139. There are two water molecules in an
extended network of hydrogen bonds that fill the other side of the pocket (Figure 3.4C). In
addition to the size restrictive pocket, the side chain of Ser1p makes hydrogen bonds to Tyr-85
and Glu-139. Arg3p makes numerous contacts with NatD as well (Figure 3.4B). The aliphatic
region of the Arg3p side chain sits on top of Tyr-136 in an extensive van der Waals interaction.
The two terminal nitrogens in the guanidino group of the side chain make hydrogen bonds with
the NatD side chains Asp-127, Glu-129, and Tyr-138. The glycines at positions 2 and 4 also
appear to be playing important roles in peptide substrate recognition by NatD. It is notable that
Gly2p is in a conformation with torsion angles that are unfavorable for any residues other than
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glycine in the Ramachandran plot (Phi: 69.59, Psi: -171.02). In addition, both Gly2p and Gly4p
are in grooves that are sterically tailored for glycines. Gly2p lies in a narrow tunnel which
connects Ser1p with the rest of the peptide and is in close contact with Lys-97 and Glu-100. Gly4p
makes intimate contacts with Trp-90, Thr-174 and Tyr-211. It appears that residues with sidechains in position 2 or 4 would thus lead to unfavorable clashes (Figure 3.4B). The majority of
the residues making contacts with the peptide are highly conserved among NatD homologs
(Figure 3.1).
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Figure 3.4 Peptide binding site of NatD (from previous page)
(A) Electrostatic surface of the NatD peptide binding site with the peptide shown in magenta stick
figure. Residues from NatD are labeled in black and residues from the peptide are labeled in
yellow with their corresponding one-letter codes and numerical positions in the peptide. The side
chain of Lys5p was disordered and not modeled into the crystal structure. (B) Detailed
interactions between NatD and the H4-H2A peptide. NatD is shown as a transparent cyan surface,
and residues that interact with the peptide are yellow. Hydrogen bonds are shown as dashed lines
and waters are shown as red spheres. (C) Close-up view of the NatD active site highlighting
interactions made by Ser1p. Acetyl-CoA was modeled into the figure by aligning the binary and
ternary NatD structures.
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3.2.2 NatD mutational analysis
To address the contribution of specific residues in substrate recognition, we prepared
point mutants to alanine for residues of interest, and assayed them for acetyltransferase activity
against a 19-residue peptide of the H4 N-terminus (Figure 3.5A). All of the mutants assayed were
purified to homogeneity in the same manner as the wild type enzyme, and displayed the same gel
filtration elution profile, suggesting that the mutants did not perturb overall protein folding.
Notably, individual mutations of residues that contribute to the intimate Gly4p interaction
(T174A, and Y211A) show wild-type catalytic efficiency (Figures 3.5A and 3.5B), consistent
with the role of these residues in specifying a glycine in position 4 of the peptide. In contrast,
mutations of residues that contact Arg3p (Y136A, Y138A, and D127A/E129A) show significantly
decreased catalytic efficiency (1.6 to 18-fold) (Figures 3.5A and 3.5B), highlighting the particular
importance of this residue for substrate-specific binding. The W90A and Y85A mutants also
exhibited significantly decreased catalytic efficiency (2.8 and 5.8-fold, respectively). The W90A
mutant lacks the stabilizing van der Waals contacts with the peptide. The decrease in activity in
the Y85A mutant is likely due to the absence of hydrophobic stabilization provided by Tyr-85 in
the α1-α2 loop that forms a part of the cavity for histone recognition, in addition to its hydrogen
bond to Ser1p (Figures 3.5A and 3.5B). Glu-100 is a highly conserved residue that may act to
position α1 and α2 through an interaction with Lys-97, another conserved residue. This is
supported by the observation that an E100A mutation exhibits a 5-fold reduction in catalytic
efficiency. Notably, Lys-97 mutants were not stable through purification (data not shown).
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Figure 3.5 Mutational analysis of NatD
(A) Catalytic efficiency of selected NatD mutants. Mutations that have negligible effect are in
blue, while those that decrease the catalytic efficiency of the enzyme are in pink. (B) Residues
targeted for mutagenesis are mapped onto the NatD structure. The color scheme is the same
as Figure 3.5A. (C) The catalytic efficiency of wild-type NatD toward N-terminal histone H4
peptides of varying length. Data are represented as mean ± SEM. Each mutant and peptide of
varying length was assayed in triplicate.
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3.2.2 NatD Catalysis
The structure of NatD suggests several potential catalytic residues. Classically,
acetyltransferases in the GNAT family use a general base residue to deprotonate the lysine side
chain or N-terminus, which carries out a nucleophilic attack on the acetyl group of acetyl-CoA
(Yuan and Marmorstein 2013). Interestingly, the type and relative location of residue that is
employed to carry out this function can differ between acetyltransferase enzymes (Vetting et al.
2005; Liszczak and Marmorstein 2013; Liszczak, Arnesen, and Marmorstein 2011). In the NatD
structure, both Tyr-136 and Glu-139 are positioned to potentially play a role as important
catalytic residues (Figure 3.4B and 3.4C). Although Tyr-136 is not close enough to deprotonate
the N-terminus directly, there is an ordered water molecule bridging its phenol oxygen and the
peptide N-terminus. This water molecule is positioned similarly to one that appears to be
involved in catalysis in NatE, which uses a tyrosine as one of its general bases (Liszczak,
Arnesen, and Marmorstein 2011). In order to distinguish between the two residues, we mutated
Tyr-136 to phenylalanine and Glu-139 to glutamine and tested the activity of these mutants.
While the catalytic efficiency of the enzyme is modestly affected by the Y136F mutation, it is
effectively abolished in the E139Q mutant, demonstrating that the catalytic residue of NatD is
likely Glu-139 (Figure 3.5A). This is in agreement with a previous study (Liu et al. 2009), and
consistent with the functional importance of Glu-139, as it is strictly conserved among NatD
proteins (Figure 3.1). As Glu-139 is not positioned to directly deprotonate the N-terminus, it may
not act as a general base but instead increase the nucleophilicity of the N-terminus through an
induced dipole effect from the carboxylic acid side-chain. Glu-139 may also be important for
orienting the amino group properly across from the acetyl-CoA. This is similar to Glu-24 in
NatA, which is not directly positioned to deprotonate the N-terminus, but is still essential for
catalysis (Liszczak et al. 2013).
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Our results are in contrast to previous reports on the catalytic requirements of NatD. A
previous modeling study predicted that Cys-137 could also act as an important residue in the
catalytic mechanism of NatD (Jedrzejewski and Kazmierkiewicz 2013), in a mechanism similar
to MYST family acetyltransferases (Yan et al. 2002). However, the cysteine is not in a suitable
position in the structure to act as an acetyl group acceptor, and while the C137A mutant does
show a decrease in activity, it still retains much of its catalytic power (Figure 3.5A). Previous
studies also suggested that NatD requires a longer N-terminal tail than other NATs in order to
recognize its histone H4 and H2A substrates. In particular, in an in vivo assay in S. cerevisiae, it
was found that a chimeric cytochrome C with H4 N-termini showed complete acetylation with
chimeric proteins containing 50 N-terminal H4 residues, and only incomplete acetylation with
chimeric proteins containing 30 N-terminal H4 residues (Polevoda, Hoskins, and Sherman 2009).
However, when we tested synthetic H4 peptides of varying length (five, eight, and nineteen
residues) we did not see a significant difference in catalytic efficiency (Figure 3.5C). This result
is in agreement with the crystal structure suggesting that the determinants for NatD-specific
binding and acetylation is contained within the first four N-terminal residues. It also is consistent
with a previous study that showed that NatD substrate specificity is not affected by residues past
the 5th position in a peptide when the enzyme was tested against a library of oligopeptides (Hole
et al. 2011).

3.3 Discussion and Future Directions
The structures and biochemical activities of two of the six NAT proteins have recently
been characterized, NatE (Liszczak, Arnesen, and Marmorstein 2011) and NatA (Liszczak et al.
2013). Here we report the molecular characterization of the most substrate-selective NAT
enzyme, NatD, which has been reported to acetylate the N-terminus of only two substrates
(histones H4 and H2A) that harbor the identical sequence of SGRGK in humans. We find that the
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overall fold of NatD is similar to other NATs; however, there are structural differences that
appear to be critical for maintaining protein integrity and cognate substrate binding. A novel Nterminal segment wraps around the catalytic core domain to make numerous stabilizing
interactions, and deletion analysis suggests that this N-terminal segment is required for
maintaining the stability of the catalytic core domain. We note that several NAT proteins (NatA,
NatB and NatC) require auxiliary subunits for activity and ribosome association; the NatA
structure reveals that the Naa15 auxiliary subunit wraps around the Naa10 catalytic subunit to
increase stability of the catalytic subunit to induce a conformation of Naa10 that is compatible for
catalysis (Liszczak et al. 2013). In this regard, the N-terminal segment of NatD may be playing an
analogous role as the NatA auxiliary subunit.
The N-terminal sequence requirements of NatD are quite different than other NATs. In
particular, most other NATs show the greatest specificity for residue 1 with reduced preference
for residue 2 and significantly reduced preference for residues 3 on (Starheim, Gevaert, and
Arnesen 2012). This is born out by the crystal structures of NatA and NatE bound to cognate
peptides showing the most extensive side chain interactions with residue 1 followed by residue 2
of the cognate substrate (Liszczak, Arnesen, and Marmorstein 2011; Liszczak et al. 2013). NatD,
in contrast, has sequence requirements for the first 4 residues of its substrate peptide (Hole et al.
2011). Unique structural features of NatD appear to play direct roles in substrate-specific binding
by NatD. In particular, the β6-β7 loop of NatD is oriented away from the peptide substratebinding site relative to the corresponding loops in the other NATs. Instead, the extended α1-α2
loop of NatD flips toward the peptide-binding site and in so doing tilts the path of the NatD
peptide by about 75° relative to the paths of the NatA and NatE substrates (Figure 3.3B). An
important consequence of this is that Arg3p is forced into a unique and complementary pocket of
NatD that is not present in the other NATs, and particularly not in NatA, which also acetylates Ntermini that contain a serine in position 1 (Figure 3.6A). Indeed, both NatA and NatE contain a
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conserved tyrosine (Tyr-138 in both proteins) that would sterically block peptides to be oriented
toward the β6-β7 loop as in NatD. This may be a mechanism by which NatA and NatE ensure a
broader substrate profile, as orienting the peptide away from the enzyme surface prevents
significant interaction beyond the first two residues of the N-terminus.
Similarly to NatA, the peptide-binding pocket of NatD can only accommodate residues
with small side chains as position 1 in the peptide. However, unlike NatA, the pocket is more
tailored to accommodate a serine. Tyr-85 and Glu-139 are oriented to have their side chains
precisely where the side chain of the N-terminal residue will lie in the pocket (Figure 3.4C).
Whereas the active site of NatA lacks significant electrostatic potential (Figure 3.6B), the
presence of these polar and charged residues in the active site likely makes it unfavorable for
residues with small aliphatic side chains to be the N-terminal residue in the peptide (Figure 3.6C).
In addition, the active site of pocket of NatD is even more constricted than NatA, particularly due
to the placement of Glu-139. This helps explain the preference for serine over threonine, a residue
that NatA can acetylate. Gly2p and Gly4p of the H4/H2A peptide also appear to contribute to
substrate-specific binding by NatD. Gly2p contains unusual phi/psi angles that are only favorably
accommodated by a glycine residue, and it does not appear that a residue with a side chain would
be well accommodated in positions 2 or 4 of a substrate. hNatD therefore appears to be specific
for a Ser-Gly-Arg-Gly sequence in its cognate substrate. Notably, S. cerevisiae and S. pombe
H2A have a divergent sequence of SGGKG. It was shown that heterologous expression of human
NatD in an S. cerevisiae NatD knockout strain restored N-terminal acetylation of yeast H4, but
not yeast H2A in vivo (Hole et al. 2011). Therefore, the substrate specificities of NatD
correspond to the sequences of H2A and H4 in the organism, and yeast NatD has likely evolved
to accommodate both N-termini.
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Figure 3.6 Comparison between substrate recognition of NatD and NatA
(A) Overlay of the peptide binding site of NatA (orange) and NatD (cyan with magenta histone
substrate). (B) Electrostatic potential surface of the NatA active site with a bound covalently
linked bisubstrate inhibitor. The N-terminal serine of the substrate peptide is shown in orange,
and the acetyl-CoA moiety of the bisubstrate inhibitor is in white. (C) Electrostatic potential
surface of the NatD active site. The N-terminal serine of the substrate peptide is shown in
magenta, and acetyl-CoA is in orange. Waters are shown as red spheres. Acetyl-CoA was
modeled into the figure by aligning the binary and ternary NatD structures.
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When we screened purified HsNatD and SpNatD against a panel of potential substrates,
we found that while SpNatD could acetylate the sequences SGRGK, SGKAH (S. cerevisiae
H2A.Z), and SGGKG equally well, HsNatD disfavored the SGGKG substrates (Figure 3.7). The
molecular basis for the contrasting substrate preference is unclear, as are any potential functional
consequences of H2A N-terminal acetylation in vivo. More research will be required to answer
these questions.
Given the fairly short consensus sequence of NatD, we wondered why NatD is specific
for histones H4 and H2A. We first performed a Uniprot search to query what other proteins share
an N-terminal SGRGK sequence. To our surprise, the only proteins containing this N-terminal
sequence in the human proteome are H2A, H4 and H2A.X. If we decrease our specificity by
removing Lys-5 (which does not appear to make sequence specific interactions in the structure),
there is only one other protein with an N-terminus of SGRG, SMARCD2, a SWI/SNF- related
chromatin regulator (Ring et al. 1998). There is no evidence that SMARCD2 is acetylated by
NatD, but our studies would predict that this would be the case. If we broaden the scope of
potential NatD substrates even further by searching for proteins with N-termini of SG[R/K], there
are an additional 22 proteins that meet those criteria. Although this method does not account for
N-termini generated through proteolytic cleavage, it still appears that the N-terminal proteome of
potential NatD substrates is limited relative to other NAT proteins. Further studies will have to be
carried out to establish if the pool of NatD client proteins are indeed broader than previously
appreciated.
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Figure 3.7 Substrate profiling of NatD homologues
Normalized CPM counts of HsNatD and SpNatD. Peptides are the N-termini of various
substrates. H4:19mer is a 19 residue peptide corresponding to the N-terminus of human H4, and
H4:5mer is just the pentameric N-terminus of H4. ScH2A.Z corresponds to the 19 N-terminal
residues of S. cerevisiae histone variant H2A.Z, which contains an N-terminus starting SGKAH.
ScH2A corresponds to the 19 N-terminal residues of S. cerevisiae H2A, whose first five residues
are SGGKG. SASE is a peptide with the sequence SASE at the N-terminus, which is a NatA
substrate, but not a NatD substrate.
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3.4 Materials and Methods
3.4.1 H. sapiens NatD (hNatD) expression and purification
The full-length hNatD gene (encoding residues 1–237) was a gift from Dr. Thomas
Arnesen from the University of Bergen. Several N-terminal and C-terminal truncation constructs
were engineered into a modified PCDF vector containing an N-terminal tobacco etch virus (TEV)
protease–cleavable His tag. All constructs were transformed into Rosetta (DE3)pLysS competent
E. coli cells, which were grown to an OD600 of 0.7-0.9 and induced with 0.5 mM IPTG at 16 °C
for ~16 h. All subsequent purification steps were carried out at 4°C. Cells were isolated by
centrifugation and lysed by sonication in lysis buffer containing 25 mM Tris, pH 8.0, 1 M NaCl,
10 mM β-mercaptoethanol (βME) and 10 µg/mL PMSF. The lysate was clarified by
centrifugation and passed over nickel resin (Thermo Scientific), which was subsequently washed
with >20 column volumes of lysis buffer supplemented with 25 mM imidazole. The protein was
eluted in lysis buffer supplemented with 300 mM imidazole. His tagged TEV protease was added
to the eluent containing the target protein for the duration of a 14-h dialysis into dialysis buffer
containing 25 mM Tris, pH 8.5, 200 mM NaCl, 10 mM βME. This solution was passed through
an additional nickel column to remove TEV protease as well as any uncut NatD. The resin was
then washed with approximately seven column volumes of dialysis buffer supplemented with 25
mM imidazole, which was pooled with the initial flow through. This solution was dialyzed into
ion exchange buffer containing 25 mM Tris, pH 8.5, 50 mM NaCl and 1 mM DTT and loaded
onto a 5-mL HiTrap Q ion-exchange column (GE Healthcare). The protein was eluted in the same
buffer with a salt gradient (50–750 mM NaCl) over the course of 20 column volumes. Peak
fractions were pooled and dialyzed into sizing buffer containing 25 mM HEPES, pH 7.0, 200 mM
NaCl, and 1 mM DTT for ~16 hours. This was concentrated to a volume of 500 µl (10-kDa
concentrator; Amicon Ultra, Millipore), and loaded onto and run on an s75prep gel-filtration
column (GE Healthcare) in sizing buffer. Peak fractions were concentrated to 10 mg/mL as
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measured by UV280 for crystallization trials.

3.4.2 S. pombe NatD (SpNatD) expression and purification
The full-length SpNatD gene (encoding residues 1–204) was cloned out of the S. pombe
genome (ATCC), and several N-terminal truncation constructs were engineered into a modified
pETDUET vector containing a TEV protease–cleavable His tag. All constructs were transformed
into Rosetta (DE3)pLysS competent E. coli cells, which were grown to an OD600 of 0.7-0.9 and
induced with 0.5 mM IPTG at 16 °C for ~16 h. These constructs all expressed as insoluble
inclusion bodies in Rosetta (DE3)pLysS E. coli cells. To improved solubility, a number of
constructs of the SpNatD gene were subcloned into a modified pETDUET vector containing an
N-terminal SUMO tag. These constructs were transformed and induced with IPTG in the same
way and were soluble in E. coli cells. All subsequent studies were carried out at 4°C and are
identical to the purification protocol used for purifying the human protein with the following
changes. After the nickel column, His tagged Ulp1 protease was used in place of TEV protease to
cleave the SUMO tag. The ion exchange buffer contained 25 mM HEPES, pH 7.0, 50 mM NaCl
and 1 mM DTT, and a 5-mL HiTrap SP ion-exchange column (GE Healthcare) was used. The
selenomethionine derivative was produced by expressing the SUMO tagged SpNatD (resdiues
13-204) in minimal media (Molecular Dimensions) with 50 µg/L selenomethionine (Sigma)
purified in the same manner as above.

3.4.3 NatD crystallization and data collection
hNatD (8 mg/mL) was incubated with acetyl-CoA (Sigma-Aldrich) at a 1:3 molar ratio.
Crystals were obtained with hanging-drop vapor diffusion in a drop containing a 1:1 mixture of
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protein to a well solution containing 20% PEG 3350, 200 mM sodium citrate tribasic dihydrate,
100 mM citric acid, pH 4.0. Diffraction-quality crystals grew in 2-3 days. The ternary complex
was crystallized using an hNatD construct containing residues 17-220 at 10 mg/ml. The protein
was incubated with CoA, and the C-terminally amidated substrate peptide (SGRGK— GenScript)
at a 1:3:5 molar ratio of protein:CoA:peptide. Crystals were obtained through hanging-drop vapor
diffusion at 20 °C at a 1:1 ratio of protein to a well solution containing 20% PEG 3350 and 200
mM sodium malonate, pH 6.0. Crystals grew after 1 day. SpNatD was crystallized at a
concentration of 10 mg/ml using a construct that contained residues 13-204. The protein was
mixed with acetyl-CoA at a molar ratio of 1:3 protein to acetyl-CoA. Crystals were obtained with
hanging-drop vapor diffusion at 20 °C at a 1:1 ratio of protein to well solution containing 20%
PEG 3350 and 200 mM potassium formate. Crystals grew after 1 day. Selenomethionine crystals
of SpNatD were generated in the same manner. All crystals were cryoprotected by transferring
them to their respective well solutions supplemented with 20% glycerol before being flash frozen
in liquid nitrogen. Data for the hNatD ternary complex was collected at a home source using a
MicroMax-007 HF rotating anode (Rigaku). Data for all other crystals were collected at beamline
X29A at the National Synchrotron Light Source (Brookhaven National Laboratory). All datasets
were processed using HKL2000 (Otwinowski and Minor 1997).

3.4.4 Structure Determination and Refinement
Initially, a number of full length and truncated search models based on known structures
of NATs (Liszczak and Marmorstein 2013; Liszczak et al. 2013; Liszczak, Arnesen, and
Marmorstein 2011) were used in an attempt to solve either hNatD or SpNatD structure through
molecular replacement (Mccoy et al. 2007). However, these attempts were unsuccessful in
generating a suitable starting model for either hNatD or SpNatD. A dataset was collected on the
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selenomethionine-labeled SpNatD crystals at the selenium peak wavelength (0.9788 Å), and
heavy atoms were places in the asymmetric unit and initial phases were generated using singlewavelength anomalous diffraction (SAD) phasing using SOLVE in the Phenix suite (Adams et al.
2011). The SpNatD structure was initially built into the resulting density by AutoBuild in the
Phenix suite. The rest of the structures described were solved using molecular replacement. The
selenomethionine-labeled SpNatD structure was used as a search model for the wild-type SpNatD
crystals. However, these crystals did not yield a model of sufficient quality, so only the
selenomethionine data set was refined fully. The program CHAINSAW (Stein 2008) was used to
generate a search model from the SpNatD structure for the binary hNatD structure, and the final
refined hNatD structure was used as a search model for the ternary hNatD crystals. For all of the
structures, the ligands acetyl-CoA/CoA and the substrate peptide for the ternary complex were
built into the Fo - Fc electron density map. All of the structures were refined iteratively by using
Phenix refine and manual model building in the molecular graphics program Coot (Emsley et al.
2010). The SpNatD/acetyl-CoA complex crystallized as a dimer with the N-terminus of one
monomer in the active site of another. The N-terminal serine of the enzyme is acetylated and CoA
is bound to the enzyme. This is likely an artifact of crystallization, wherein the subunit packing
positions the N-terminus of SpNatD (SRRMK), which superficially resembles the natural
substrate, in the active site. The final model and structure factors for all of the structures were
submitted to the Protein Data Bank. Refinement statistics and PDB IDs can be found in Table 3.1.

3.4.5 Acetyltransferase assays
Acetyltransferase assays were carried out in 25 mM HEPES pH 7.0, 100 mM NaCl, and 1
mM DTT. The substrate peptide used in the assay for the mutant enzymes corresponds to the first
19 residues of human H4 (NH2-SGRGKGGKGLGKGGAKRHR-COOH; GenScript). In the
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assay, a saturating amount (400 µM) of radiolabeled [14C]acetyl-CoA (4 mCi/mmol; PerkinElmer
Life Sciences) and varying concentrations of the substrate peptide (6.25 µM-200 µM) were
incubated with 75 nM NatD (500 nM for E139A and E139Q mutants) in 75 µL reaction volume
for 20-180 min. at 37 °C. To quench the reaction, 20 µL of the reaction mixture was added to
negatively charged P81 paper discs (Whatman), and the paper discs were immediately placed in
wash buffer (10 mM HEPES, pH 7.5). The paper discs were washed three times, at five minutes
per wash to remove unreacted acetyl-CoA. The papers were then dried with acetone and added to
4 ml of scintillation fluid, and the signal was measured with a Packard Tri-Carb 1500 liquid
scintillation analyzer. Background control reactions were performed in the absence of enzyme or
in the absence of substrate peptide to ensure that any possible signal due to autoacetylation was
negligible. Each reaction was done in triplicate. By keeping the substrate concentration far below
KM, we were able to plot velocity versus [substrate] and use the slope of the resulting line to
obtain kcat/KM values for the mutants based on the equation: v = (kcat/KM)[E][S]. The counts per
minute were converted to molar units using a standard curve of known [14C]acetyl-CoA
concentrations in scintillation fluid. The assay was performed in the same manner for substrate
peptides corresponding to the first five and eight residues of human H4 (SGRGK and
SGRGKGGK, respectively) with wild-type hNatD, and for the assays against the range of
substrates in Figure 3.7. The sequences for those peptides are as follows (H4:19mer and 5mer
sequence in same as above):
ScH2A.Z: SGKAHGGKGKSGAKDSGSL
ScH2A: SGGKGGKAGSAAKASQSRS
SASE: SASEAGVRWGRPVGRRRRP
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CHAPTER 4: The N-terminal Acetyltransferase Naa10/ARD1 Does Not Acetylate Lysine
Residues

This research was originally published in The Journal of Biological Chemistry (Magin, March,
and Marmorstein 2016) © the American Society for Biochemistry and Molecular Biology
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4.1 Introduction
There are five conserved NATs found in eukaryotes termed NatA-NatE. These enzymes
differ in their N-terminal substrate profiles (Starheim, Gevaert, and Arnesen 2012). NatA, which
is responsible for the plurality of N-terminal acetylation (Starheim, Gevaert, and Arnesen 2012),
is a heterodimeric complex consisting of a catalytic subunit termed Naa10 (previously known as
Ard1) and an auxiliary subunit termed Naa15 (previously known as NATH or Nat1) (Mullen et
al. 1989). NatA acetylates N-termini containing an N-terminal residue that has a small radius of
gyration: alanine, cysteine, glycine, serine, threonine, and valine (Polevoda and Sherman 2003).
Structural and enzymatic studies reveal that the enzymatic subunit Naa10 has a different substrate
profile when it is not in complex with the auxiliary subunit Naa15. As a monomer, Naa10
acetylates N-termini in which the N-terminal residues are acidic, such as actin, whose first three
N-terminal residues are glutamates (Liszczak et al. 2013; Van Damme, Evjenth, et al. 2011).
Recent reports claim to have identified lysine substrates for monomeric Naa10. These
include the transcription factor Runx2 (Yoon et al. 2014), the enzyme methionine sulfoxide
reductase A (MSRA) (Shin et al. 2014), and myosin light chain kinase (MLCK) (Shin et al.
2009). These findings were surprising to us since the structure of all NATs determined to date
(Vetting et al. 2008; Liszczak, Arnesen, and Marmorstein 2011; Liszczak et al. 2013; Liszczak
and Marmorstein 2013), including Naa10 (Liszczak et al. 2013), contain an extended loop, which
seem to occlude lysine side chains within a polypeptide from lying across the active site as they
do in KATs (Dorfel and Lyon 2015; Liszczak, Arnesen, and Marmorstein 2011; Magin, Liszczak,
and Marmorstein 2015a; Liszczak and Marmorstein 2013). In addition, other reports
demonstrating that Naa10 acetylates a lysine residue on Hif-1α have failed to be replicated (Jeong
et al. 2002; Murray-Rust et al. 2006; Arnesen et al. 2005), making the question of whether Naa10
is able to acetylate lysine residues controversial. We therefore performed a number of
experiments to investigate this question. We found that the addition of acetyl-CoA did indeed
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promote the acetylation of MSRA and Runx2, but that this acetylation was Naa10-independent.
Based on this observation, we conclude that lysine residues on these substrates are not acetylated
by Naa10 but are instead acetylated by chemical means.

4.2 Results
4.2.1 The structure of Naa10 and other NATs are incompatible with lysine acetylation
A superposition of Naa10 (Liszczak et al. 2013) and the Gcn5 KAT (Rojas et al. 1999)
bound to their cognate N-terminal and lysine peptide substrates, respectively, illustrates why
these enzymes are tailored to acetylate their respective substrate (Figure 4.1A). Specifically, the
Gcn5 KAT bound to a histone tail peptide centered on the lysine 14 target reveals that the peptide
sits across a wide surface groove of the enzyme with the central lysine 14 residue inserting into
an a narrow active site cavity (Rojas et al. 1999) (Figure 4.1A). The Hat1 histone
acetyltransferase KAT bound to a histone H4 peptide shows a similar substrate-binding
configuration (Li et al. 2014). The Naa10 NAT and Gcn5 KAT superimpose fairly well (RMSD =
6.4) except for the substrate binding sites (RMSD = 10.17). Most notably, Naa10 contains an
extended loop between β-strands β6 and β7, that is not present in Gcn5, that blocks peptide
binding across the surface groove that is present in Gcn5 (Figure 4.1A). Instead, Naa10 contains
an active site cavity that can only accommodate an N-terminal peptide (Figure 4.1A). A
superposition of all available NAT structures (Vetting et al. 2008; Liszczak, Arnesen, and
Marmorstein 2011; Liszczak et al. 2013; Liszczak and Marmorstein 2013; Magin, Liszczak, and
Marmorstein 2015a) reveal that they contain substrate binding sites that are tailored for Nterminal substrate binding oriented similar to Naa10 and incompatible with binding lysinecontaining substrates oriented similar to Gcn5 (Figure 4.1B).
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Figure 4.1 The structure of NATs is incompatible with lysine acetylation
(A) Superposition of the Gcn5 KAT-histone H3 peptide complex (dark and light blue,
respectively) with the Naa10 N-terminal peptide complex (yellow and wheat, respectively). The
proteins are shown as cartoon and the peptide ligands are shown as sticks. Naa10 is shown with
its β6-β7 loop in orange. (B) Superposition of NAT/N-terminal peptide complexes with Naa10
(yellow), Naa40 (salmon) Naa50 (green), and the NAT from Sulfolobus solfataricus (ssNAT,
purple).
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4.2.2 Naa10 does not acetylate lysine residues within peptides from MLCK, MSRA, or RUNX2
Although the structural superpositions described above argue against Naa10 acetylation
of lysine substrates, it remains possible that Naa10p may be able to adopt an alternative
conformation to accommodate lysine substrate acetylation. To address this possibility, we first
tested whether recombinant Naa10 was able to acetylate peptides corresponding to published
lysine substrates (Yoon et al. 2014; Shin et al. 2014; Shin et al. 2009). These peptides were
approximately 20 residues long, and contained the reported lysine in the center of the peptide. We
assayed three reported substrates: MLCK, MSRA and Runx2, and a peptide corresponding to the
N-terminus of actin, a known Naa10 substrate, as a positive control (Liszczak et al. 2013; Van
Damme, Evjenth, et al. 2011). We carried out acetyltransferase assays with a saturating
concentration of peptide (1 mM) and radiolabeled acetyl-CoA and measured the signal by
scintillation counting. While Naa10 robustly acetylated its canonical actin substrate, there was no
difference in the levels of acetylation in the three substrates in the absence or presence of Naa10
(Figure 4.2A). These experiments reveal that Naa10 does not contribute to the acetylation of
MLCK, MSRA and Runx2 lysine peptide substrates.
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Figure 4.2 Naa10 does not acetylate peptides or proteins corresponding to reported lysine
substrates
Recombinant human Naa10 was used for these experiments. (A) Radioactive filter binding assay
of peptide acetylation in the presence or absence of Naa10. An N-terminal actin peptide was used
as a positive control. (B) Radioactive TCA precipitation assay of protein acetylation with Runx2
and MSRA in the presence of absence of Naa10. The experiments were carried out in triplicate,
and error bars are indicated. CPM, counts per minute.
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4.2.3 Naa10 does not acetylate lysine residues within MSRA and RUNX2 proteins
To address the possibility that an expanded recognition motif on the substrates might be
required for acetylation by Naa10, we subsequently performed the acetylation reactions using
intact protein substrates or domains. To do this, we recombinantly expressed the Runt domain
from Runx2, and full length MSRA. We incubated the proteins or actin peptide (50 uM) with
radiolabeled acetyl-CoA in the presence and absence of Naa10. After allowing the reaction to
take place for 4 hours, we added trichloroacetic acid (TCA) to precipitate protein and quantified
acetylated protein in the pellet by scintillation counting. Once again, we did not observe any
difference in the level of acetylation of the substrates with or without Naa10 present, in contrast
to the acetylation of actin, which showed enzyme dependence (Figure 4.2B). The difference in
the counts for the actin control in Figure 4.2 are due to the use of 1 mM substrates in the
experiments done in Figure 4.2A and the use of 50 uM substrates in Figure 4.2B. The different
concentrations reflect the nature of the experiments done.
To evaluate the nature of acetylation of the substrates that was observed, we carried out
reactions with increasing concentrations of acetyl-CoA in the presence and absence of Naa10.
This analysis revealed that while Naa10 displayed Michaelis-Menten kinetics against its actin
substrate (Figure 4.3A), it showed first order kinetics against Runx2 and MSRA (Figures 4.3B
and 4.3C). When Naa10 was omitted from the reaction, the acetylation against actin was
negligible, while the acetylation of Runx2 and MSRA did not change (Figure 4.3). These data
strongly suggest that the acetylation of Runx2 and MSRA are independent of Naa10, and are
therefore not enzymatic events, but instead are chemical events.

93

Figure 4.3 The kinetic profiles of Naa10 against MSRA and Runx2 are indicative of
chemical acetylation
Radioactive assay against (A) N-terminal actin peptide, (B) MSRA, and (C) Runx2 at increasing
concentrations of acetyl-CoA in the presence (circles) and absence (squares) of Naa10. The
experiments were carried out in triplicate, and error bars are indicated. CPM, counts per minute.
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To perform an orthogonal assay for potential Naa10p-mediated lysine acetylation, we
also performed a Western blot with two different antibodies that recognize acetylated lysines
(Cell Signaling – Cat No. 9681 and ImmuneChem – Cat No. ICP0380). In the previously reported
studies claiming Runx2 and MSRA acetylation by Naa10, the antibody from Cell Signaling was
employed (Yoon et al. 2014; Shin et al. 2014). We also used the same buffer conditions in the
assay that were reported in the prior studies. Since there is no known lysine substrate of Naa10,
we used acetylation of the histone tetramer H3/H4 by hMOF as a positive control, as this is a
well-studied enzyme-dependent lysine acetylation event (Yuan et al. 2012). In agreement with the
radioactive assays, there was no difference in the signal between lysine acetylation whether
Naa10 was present or not for both Runx2 and MSRA (Figure 4.4), confirming that the larger
intact protein substrates or domains could not be acetylated by Naa10. In fact, the Cell Signaling
antibody detected a signal in the samples without any acetyl-CoA added, suggesting that the
Runx2 and MSRA proteins may undergo chemical acetylation while overexpressed in E. coli.
This contrasts with H4, which was only efficiently acetylated in the presence of both hMOF and
acetyl-CoA (Figure 4.4).
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Figure 4.4 Western blotting detection of acetylated MSRA and Runx2 shows independence
of Naa10
(A, B) Western blotting analyses using two different antibodies from (A) Cell Signaling
Technology (catalog no. 9681) and (B) ImmuneChem (catalog no. ICP0380) in the absence or
presence of acetyl-CoA and Naa10 with MSRA and Runx2 as substrates. The hMOF KAT with
histone H3/H4 substrate was used as a positive control. Coomassie staining of the gel is shown at
the bottom.
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4.2.4 Naa10 in the context of the NatA complex cannot acetylate lysine residues
To address the possibility that Naa10 requires assembly into the Naa10/Naa15 NatA
complex for acetylating lysine substrates, we prepared a recombinant human NatA complex in
insect cells and assayed its ability to acetylate lysine residues in the context of peptide and protein
substrates. As shown in Figure 4.5, these results are identical to those with Naa10, indicating that
Naa10 in the NatA complex is unable to acetylate Runx2 and MSRA.

4.2.5 Naa10 and NatA do not interact with MRSA and Runx2
Previous reports have claimed that Naa10 directly interacts with MRSA and Runx2
(Yoon et al. 2014; Shin et al. 2014). To address the possibility that Naa10 or NatA may at least
interact with the putative lysine containing substrates in MRSA and Runx2, we carried out
pulldown studies. We performed the pulldown by using GST-tagged MSRA and Runx2. In
contrast to previous reports, we were unable to detect an interaction between Naa10 and either
substrate (Figure 4.6A). Similar studies with the NatA complex also failed to show an interaction.
Specifically, while Naa50 successfully pulled down NatA as previously reported (Gautschi et al.
2003), MSRA and Runx2 did not (Figure 4.6B-C). Taken together, these studies failed to detect a
direct interaction of Naa10p and NatA with MRSA or Runx2.
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Figure 4.5 NatA does not acetylate peptides or proteins corresponding to reported lysine
substrates
Recombinant human Naa10/Naa15 (NatA) was used for these experiments. (A) radioactive filter
binding assay of peptide acetylation in the presence or absence of Naa10. An N-terminal SASE
peptide was used as a positive control. (B) Radioactive TCA precipitation assay of protein
acetylation with Runx2 and MSRA in the presence of absence of Naa10. The experiments were
carried out in triplicate, and error bars are indicated.
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Figure 4.6 Naa10 and NatA do not interact with MSRA or Runx2
(A) GST pulldown assays of Naa10 using GST tagged Runx2 and MSRA. Coomassie staining of
SDS-PAGE is shown for both the input (left) and elution (right). Corresponding migrating
proteins in the gels are labeled. (B) GST pulldown assays of NatA using GST-tagged Runx2 and
MSRA. The experiment was carried out as described in (A). (C) As a positive control, pulldowns
of NatA were carried out using GST-tagged Naa50. Asterisks indicate free hydrolyzed GST.
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4.3 Discussion
Acetylation has long been recognized as an important protein modification (Allfrey,
Faulkner, and Mirsky 1964). Although much of the early research examined its role as a histone
modification (Verdin and Ott 2015), studies have found that thousands of non-histone proteins are
acetylated in cells, showing that the modification is much more widespread than initially thought
(Choudhary et al. 2009). Despite the expansion in the number of lysines targeted for acetylation,
the enzymes responsible for, and the functional consequences of the majority of these marks
remains unknown.
The data presented here suggest that the acetylation of Runx2 and MSRA is not an
enzymatic event, but rather a chemical one. As a moderately reactive high-energy acetyl-donor,
acetyl-CoA can acetylate lysines in the absence of an enzyme under the right. This is particularly
true if the lysine is located in close proximity to other basic residues, which lowers the pKa of the
epsilon amino group to allow for a nucleophilic attack on the acetyl group (Baeza, Smallegan,
and Denu 2015; Olia et al. 2015). Indeed, the lysines reported for both Runx2 and MSRA cluster
within a basic patch on the proteins (Tahirov et al. 2001; Lowther et al. 2000) (Figure 4.7).
The results presented here are in contrast to previous reports claiming that Naa10 is able
to acetylate lysine residues within several protein targets including Runx2, MSRA, and
MLCK (Yoon et al. 2014; Shin et al. 2014; Shin et al. 2009). This discrepancy can be explained
by a number of factors. The authors of the previous studies generated knockouts of Naa10 in mice
and tissue culture for many of the assays performed. However, as the NatA complex targets
hundreds of proteins for acetylation, pleiotropic effects can occur upon depletion or
overexpression of the protein, the causes for which can be difficult to decipher. This is reflected
in the diverse phenotypes found in NatA null yeast (Mullen et al. 1989). Therefore, the in vivo
and cell-based results must be interpreted with caution. In the in vitro system described here,
neither Naa10 alone nor Naa10 in the context of the NatA complex is observed to acetylate or
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interact with these putative lysine substrates. Instead, we found that these substrates are
chemically acetylated. Chemical acetylation of lysines has been shown to be an important
modification in its own right, and it may be significant for regulating these proteins as well.

Figure 4.7 The acetylated lysines in MSRA and Runx2 are found in proximity to basic
residues that could facilitate chemical acetylation
Crystal structures of (A) bovine MSRA and (B) murine Runx1 (90% identity to Runx2),
highlighting the lysines within these proteins reported to be acetylated by Naa10 (yellow) as well
as proximal basic residues (salmon).
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4.4 Materials and methods
4.4.1 Cloning and purification of Naa10
The gene encoding full length human Naa10 (residues 1-235) was cloned into a
pETDUET vector containing an N-terminal His6-SUMO tag. The resulting construct was
transformed into Rosetta (DE3)pLysS competent E. coli. Cells were grown to OD600 0.7-0.9 prior
to inducing protein expression with 0.5 mM isopropyl β-d-1-thiogalactopyranoside (IPTG) at
16°C for ~16 hr. All subsequent purification steps were carried out at 4°C. Cells were isolated by
centrifugation and lysed by sonication in lysis buffer containing 25 mM Tris, pH 8.0, 1 M NaCl,
10 mM β-mercaptoethanol (βME) and 10 µg/ml phenylmethanesulfonylfluoride (PMSF). The
lysate was clarified by centrifugation and passed over 6 ml of Ni-NTA resin (Thermo Scientific),
which was subsequently washed with 500 ml of lysis buffer supplemented with 25 mM
imidazole. The protein was eluted in 50 ml of lysis buffer supplemented with 300 mM imidazole
and dialyzed into ion exchange buffer containing 25 mM Tris pH 8.5, 50 mM NaCl, and 10 mM
βME and loaded onto a 5 ml Q ion exchange column (GE Healthcare). The protein was eluted in
the same buffer with a salt gradient (50-750 mM NaCl) over the course of 20 column volumes.
Peak fractions were pooled, concentrated to 500 µl, and loaded onto an s200 gel filtration column
(GE Healthcare) in sizing buffer containing 25 mM HEPES pH 7.0, 200 mM NaCl, and 1 mM
DTT. Peak fractions were pooled and concentrated. Proteins were aliquotted, snap-frozen in
liquid nitrogen, and stored at -80 °C for further use. A portion of the protein was then incubated
with Ulp1 protease overnight to cleave off the His6-SUMO tag in sizing buffer. After cleavage,
this solution was subjected to an additional Ni-NTA purification step to remove Ulp1, His6SUMO, and any uncut Naa10 fusion protein. The resin was then washed with approximately ten
column volumes of dialysis buffer supplemented with 25 mM imidazole, which was pooled with
the initial flow-through. The protein was concentrated to 500 µl and run on a Superdex 75 gel
filtration column. Peak fractions were pooled and concentrated. Proteins were aliquotted,
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supplemented with 5% glycerol, snap-frozen in liquid nitrogen, and stored at -80 °C for further
use.

4.4.2 Cloning and purification of NatA and GST-Naa50
Human Naa10 (residues 1-160) and Naa15 (residues 1-866) constructs were engineered
using a pFastBac dual vector. The Naa15 subunit contained an N-terminal His6-tag. A bacmid
was generated by transposition into DH10 bac competent Escherichia coli cells using the bac-tobac system (Invitrogen). Spodoptera frugiperda (Sf9) cells cultured in SFM II medium were
transfected with the Naa10/Naa15 bacmid using cellfectin reagent (Invitrogen). The resulting
baculovirus was amplified until reaching a high titer. Sf9 cells were grown to a density of
1x106 cells/ml and infected using the amplified Naa10/Naa15 baculovirus to an MOI (multiplicity
of infection) of ~1-2. The cells were grown at 27°C and harvested 48 hours post-infection. All
subsequent purification steps were carried out at 4°C. Cells were isolated by centrifugation and
lysed by sonication in lysis buffer containing 25 mM Tris, pH 8.0, 1 M NaCl, 10 mM βME, 10
µg/ml PMSF, and DNase. The lysate was clarified by centrifugation and passed over 6 ml of NiNTA resin (Thermo Scientific), which was subsequently washed with 500 ml of lysis buffer
supplemented with 25 mM imidazole. The protein was eluted in 50 ml of lysis buffer
supplemented with 300 mM imidazole. The protein was concentrated to 500 µl, and loaded onto a
Superdex 200 gel filtration column (GE Healthcare) in sizing buffer containing 25 mM HEPES
pH 7.0, 200 mM NaCl, and 1 mM DTT. Peak fractions were pooled and concentrated. Proteins
were aliquotted, snap-frozen in liquid nitrogen, and stored at -80 °C for further use. Human GSTNaa50 was purified as described (Liszczak, Arnesen, and Marmorstein 2011) with the following
changes: the protein was not cleaved with TEV protease and was run on a Superdex200 gel
filtration column.
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4.4.3 Cloning and purification of Runx2 and MSRA
The genes encoding the runt domain of mouse Runx2 (residues 186-315), and full length
human MSRA (residues 1-235) were ordered from Bio Basic. These were both cloned into a
modified pETDUET vector containing a TEV-cleavable, N-terminal GST tag. The resulting
constructs were transformed into Rosetta (DE3)pLysS competent E. coli. Cells were grown to
OD600 0.7-0.9 prior to inducing protein expression with 0.5 mM IPTG at 16°C for ~16 hr. All
subsequent purification steps were carried out at 4°C, and were identical for both proteins except
where noted. Cells were isolated by centrifugation and lysed by sonication in lysis buffer
containing 25 mM Tris, pH 8.0, 1 M NaCl, 10 mM βME and 10 µg/ml PMSF. The lysate was
clarified by centrifugation and incubated with 6 ml glutathione resin (Thermo Scientific) for one
hour. The resin was subsequently washed with 500 ml of lysis buffer. The protein was eluted in
50 ml lysis buffer supplemented with 20 mM reduced glutathione (Sigma) and dialyzed into ion
exchange buffer containing 25 mM sodium citrate pH 5.5, 25 mM NaCl, and 10 mM βME and
loaded onto a 5 ml SP ion exchange column (GE Healthcare). The protein was eluted in the same
buffer with a salt gradient (25-750 mM NaCl) over the course of 20 column volumes. Peak
fractions were pooled, concentrated to 500 µl, and loaded onto an s200 gel filtration column (GE
Healthcare) in sizing buffer containing 25 mM HEPES pH 7.0, 200 mM NaCl, and 1 mM DTT.
Peak fractions were pooled and concentrated. Half of the protein was then incubated on
glutathione resin with TEV protease overnight in sizing buffer to cleave off the GST tag. After
cleavage, the resin was washed with approximately ten column volumes of sizing buffer, and the
untagged protein was collected. The protein was concentrated to 500 µl and run on a
Superdex200 gel filtration column. Peak fractions were pooled and concentrated. Proteins were
aliquotted, supplemented with 5% glycerol, snap-frozen in liquid nitrogen, and stored at -80 °C
for further use.
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4.4.4 Acetyltransferase assays against peptides
Acetyltransferase assays were carried out in sizing buffer. All peptides were ordered from
GenScript. The peptides for the reported lysine substrates corresponded to ~20 residues
surrounding putative acetylated lysine. These peptides were ordered with acetylated N-termini to
ensure that signal would not result from N-terminal acetyltransferase activity. Tryptophan was
added to the C-terminus to allow for accurate concentration determination. The peptides were as
follows: MLCK- TVHEKKSSRKSEYLLPVAW, MSRA- RKEQTPVAAKHHVNGNRTVW,
Runx2- QVATYHRAIKVTVDGPRW. The actin substrate peptide used was previously described
in (Liszczak et al. 2013). In the assays, 300 µM of radiolabeled [14C]acetyl-CoA (4 mCi/mmol;
PerkinElmer Life Sciences), 1 µM Naa10 or NatA, and 1 mM peptide were reacted in 50 µl of
total reaction volume for 4 hours at 37 °C. To quench the reaction, 15 µl of the reaction mixture
was added to negatively charged P81 paper (Millipore), and the paper disks were immediately
placed in wash buffer (10 mM HEPES, pH 7.5). The papers were washed three times, at 5
minutes per wash, to remove unreacted acetyl-CoA. The papers were then dried with acetone and
added to 4 ml of scintillation fluid, and the signal was measured with a Packard Tri-Carb 1500
liquid scintillation analyzer.
4.4.5 Acetyltransferase assays against protein domains
Reactions were performed as above but with 50 µM substrate (Actin peptide,
recombinant Runx2, or recombinant MSRA). 15 µl of 20% trichloroacetic acid (TCA) was added
to 15 µl reaction mixture to precipitate acetylated substrates. The substrates were allowed to
precipitate on ice for 10 minutes. The precipitated substrates were pelleted by centrifuging for 5
minutes at 13,000 rpm. The supernatant was discarded and 200 µl of cold acetone was added to
wash the pellets. These were incubated on ice for 5 minutes before centrifuging at 13,000 rpm.
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This wash step was repeated twice more. The pellets were added to 4 ml scintillation fluid, and
the signal was measured with a Packard Tri-Carb 1500 liquid scintillation analyzer.

4.4.6 Acetyltransferase assays with increasing concentrations of acetyl-CoA
The assays were done as the TCA precipitation assays with the following changes. 1 mM
of substrate (Actin peptide, recombinant Runx2, or recombinant MSRA) was used, and the
amount of acetyl-CoA was varied (150 µM- 1000 µM). The reactions took place for 20 minutes at
37°C.

4.4.7 Protein pull downs
All pull downs were performed in sizing buffer. 1 µM of GST, GST-Runx2, GSTMSRA, or GST-Naa50 (positive control for NatA) were incubated with either 5 µM Naa10 or 5
µM NatA and 75 µl of glutathione resin in a total volume of 400 µl for 1 hour at 4 °C. The resin
was washed with 5 ml of sizing buffer and eluted with 100 µl of buffer supplemented with 20
mM glutathione.

4.4.8 Acetyltransferase assay followed by Western blot
300 µM of acetyl-CoA (Sigma), 1 µM enzyme (Naa10 or hMof), 50 µM substrate
(Runx2, MSRA, or the histone dimer H3/H4) were reacted in 20 µl of reaction volume for 4
hours at 37 °C. The reaction was performed in a buffer containing 50 mM Tris pH 8.0, 0.1 mM
EDTA, 1 mM DTT, 10 mM sodium butyrate, 100 mM NaCl, and 10% glycerol. To quench the
reaction, loading dye was added. Reactions were diluted to 200 µl, and 20 µl of the dilution were
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run on the gel. Two different anti-acetyl-lysine antibodies were used (Cell Signaling (#9681) and
ImmuneChem (ICP0380)). hMof and histones were prepared as described (Daniel Ricketts et al.
2015; Yuan et al. 2012).
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CHAPTER 5: Probing the Interaction Between NatA and Ribosome for Co-Translational
Protein Acetylation

Magin et al. 2017, in preparation
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5.1 Introduction
As has been discussed above, many NATs act co-translationally. They interact with the
ribosome near the exit tunnel and acetylate the nascent protein chain as it is being translated.
While the structures of many of the NATs have been determined, the molecular basis for the
interaction with ribosome has remained elusive. A significant amount of research has also been
done on other peptide modifying enzymes which bind near the ribosome exit tunnel
Based on this previous research, we sought to determine the molecular basis for the
interaction of NatA with the ribosome, particularly in the structural determinants of NatA that
mediate this interaction. We chose NatA, since it is the best characterized NAT both structurally
and functionally (Liszczak et al. 2013; Aksnes et al. 2016; Weyer et al. 2017). By using the
rationale that the NATs are likely to act similarly to MAP and PDF, we found that NatA forms a
stable complex with the ribosome in the absence of other stabilizing factors and through two
conserved regions; primarily through an N-terminal domain and an internal basic helix. These
regions may orient the active site of the NatA to face the peptide emerging from the exit tunnel.
These findings will contribute to future studies to decouple NatA N-terminal acetyltransferase
activity from ribosome association.

5.2 Results
5.2.1 NatA mediates a salt-dependent interaction with the ribosome
In order to study the NatA-ribosome interaction, we developed a purification for
Schizosaccharomyces pombe ribosome, as the structure of S. pombe NatA is known and is readily
recombinantly expressed in E. coli (Liszczak et al. 2013). We first tested whether NatA and the
ribosome would co-elute from a Superose 6 size exclusion column as a stable complex. When run
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alone, NatA elutes from the column at fraction 12 (Figure 5.1A). However, when an excess of
NatA is run with the ribosome, there is a clear shift in the position of the NatA, which coelutes
with the ribosome earlier in the column. Importantly, the excess NatA eluted at the same volume
as NatA alone (Figure 5.1B), suggesting that the complex is stoichiometric and that the ribosome
does not non-specifically mediate aggregation of NatA. This result indicates that the purified
NatA and ribosome can form a complex in vitro with no other mediating factors.
We then performed co-sedimentation analysis on the NatA-ribosome complex. We first
carried out a sedimentation assay with increasing concentration of ribosome to observe the
binding profile of NatA and the ribosome (Figure 5.2A). We calculated the proportion of NatA in
the pellet and supernatant fractions after spinning down in an ultracentrifuge. We assumed the
stoichiometry of the NatA:ribosome complex to be 1:1, based on a number of factors. First, many
proteins that bind near the exit tunnel of the ribosome have 1:1 stoichiometry (Bingel-Erlenmeyer
et al. 2008; Kohler et al. 2009; Ataide et al. 2011; Ferrández-Ayela et al. 2013). Second, in pull
down assays, the band intensity indicated a 1:1 stoichiometry of the Naa15 band with the rest of
the ribosome bands (see WT sample for Figure 5.7 below). When we compared the band intensity
of the Naa15 and the first two ribosomal proteins around 41 kD, we obtained a ration of 1.13, and
1.28, which agrees best with a 1:1 stoichiometry. Third, the curve fit very well to a 1:1 model,
with an R2 value of 0.94. Despite this reasoning, we cannot definitively state that the binding is
1:1, and more research will be necessary to conclusively determine the stoichiometry. After
fitting the curve, we found that the complex had a Kd of 0.85 ± 0.23 µM, which is similar to the
calculated Kd of both methionine aminopeptidase (Sandikci et al. 2013), and the signal
recognition particle (Bornemann et al. 2008), which are both in the low µM- mid nM range
(Figure 5.2B).
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Previous studies showed that the NatA-ribosome interaction is salt dependent in vivo. We
performed the same analysis with our purified NatA and ribosome. We found that the same held
true in our experiment. As the salt concentration increased, the interaction weakened until the
ribosome no longer pulled down any NatA (Figure 5.2C).

Figure 5.1 NatA binds to the ribosome in vitro
(A) Fractions of NatA eluting off of a Superose 6 column and visualized on SDS-PAGE. The
upper band is Naa15 and the lower band is Naa10. (B) Fractions of the ribosome and an excess of
NatA eluting off of a Superose 6 column and visualized on SDS-PAGE. Note the excess NatA
eluting in fraction 12.
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Figure 5.2 The NatA ribosome interaction has low µM affinity and is salt dependent
(A) Western blot of NatA/ribosome co-sedimentation assay. P stands for pellet, and S stands for
supernatant. The western blot targets the His tag on the Naa15 subunit (Naa10 is untagged) (B)
An affinity curve of the ribosome NatA interaction quantified from the co-sedimentation assay
(C) Co-sedimentation assay in increasing salt concentrations. The first two lanes are NatA
without ribosome present.
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5.2.2 Cryo-EM reconstruction of the NatA ribosome complex showed no density for NatA
In order to determine the mode of binding of NatA to the ribosome, we performed EM
analysis on the complex. We performed GraFix (Stark 2010) to stabilize the complex, and ran the
crosslinked and uncrosslinked samples side by side to ensure that the NatA and ribosome
sedimented together and that the Naa15 band crosslinked to higher molecular weight bands
(Figure 5.3).. Negative staining revealed distinct, homogenous ribosomal particles (data not
shown).
After obtaining good classes from negative staining, subjected the samples to cryo-Em
analysis (Figure 5.4A). We froze the samples on thin carbon and picked 54645 particles after
motion correcting the images. Only 30,000 of these particles were subsequently analyzed for
computational ease. After class averaging, our 2D classes were highly converged and displayed
obvious features of the ribosome, such as its large and small subunits (Figure 5.4B), and we then
went on to generate 3D reconstructions. The program VIPER generated five separate 3D classes,
with two classes having fewer than 2000 particles that did not converge on a structure (Figure
5.5A). The other three classes converged to ribosome structures, with the first class of 10073
particles being the best representation of the ribosome (Figure 5.5A). Unfortunately, although the
density was clear for both the 40S and 60S subunits of the ribosome, no additional density for the
NAT was apparent (Figure 5.5B). This could be due to a number of factors. Although NatA
appeared to be crosslinked to the ribosome in the gel from the GraFix (Figure 5.3), this wasn’t
necessarily the case. NatA could have been crosslinked to other contaminants in the sample, or to
itself, and only appeared to be crosslinked to the ribosome. In addition, the NAT may not have
been homogeneously bound to the ribosome, and the density was therefore lost during class
averaging. It may be that NatA was only successfully bound to a small subset of the ribosomes,
and many more particles will need to be picked for a successful reconstruction. Finally, it may be
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that the thin carbon on the surface of the grid affected the interaction between the ribosome and
NatA, and further screening of cryo-EM conditions will be required in the future.

Figure 5.3 GraFix of the ribosome/NatA complex
(A) Purified NatA and ribosome run on a sucrose gradient with an excess of NatA. Note the
excess NatA sedimenting at a higher sucrose than the ribosome/NatA complex as in Figure 5.1A.
Asterisks indicate fractions which are shown in Figure 5.3B (B) Indicated fractions of the
NatA/ribosome complex run in a sucrose gradient in the presence of 0.25% glutaraldehyde. Note
the Naa15 band, and some ribosomal protein bands are no longer present in these fractions,
indicating that they have been crosslinked to higher molecular weight species.
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Figure 5.4 Cryo-EM images and2D class averages of the NatA/ribosome sample
(A) Cryo-electron micrographs of NatA/ribosome samples on thin carbon imaged with a Falcon II
direct electron detector (FEI) equipped with an F20 electron microscope (FEI) operated at 200 kV
acceleration voltage. (B) Representative 2D class averages of NatA/ribosome samples using a
subset of 30,000 particles from 1351 images using RELION. Red Xs indicate class averages that
were not used for the 3D reconstruction.
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Figure 5.5 3D Reconstruction of the NatA/ribosome complex
(A) Five 3D classes were generated using the program VIPER (SPARX), by using a 60 Å low
pass filter of the ribosome as a reference model. Two of these classes, indicated by red Xs did not
converge on a final model. We chose the best fitting model to the ribosome, indicated by a
rectangle for further analysis. (B) Analysis of the electron density from model 1 in Figure 5.5A.
Ribosomal features are indicated. Note that there is no extra density around the peptide exit
tunnel.
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5.2.3 Two conserved electropositive regions in NatA are responsible for ribosome interaction
In the absence of structural data, we based our hypothesis on the nature of the interaction
from the similarity of the ribosome affinities of methionine aminopeptidase, signal recognition
particle, and NatA. Their shared ribosomal binding site and salt dependence for ribosome
interaction led us to hypothesize that the NatA-ribosome interaction was similar to other protein
interactions at the exit tunnel, and was largely dependent on electrostatic interactions. Therefore,
we searched for conserved electropositive regions on the surface of NatA, which could account
for this (Figure 5.6). We reasoned that electropositive regions would likely interact with the
ribosome via L23 and rRNA. We generated a conservation map onto NatA (Ashkenazy et al.
2016) and compared that to the calculated vacuum electrostatics on the protein (Figure 5.6B and
5.6C). We focused on Naa15, as this subunit has previously been shown to mediate the
interaction with the ribosome (Polevoda et al. 2008). There were two notable regions that we
found on the surface of Naa15 that were conserved and electropositive. One was within an Nterminal domain of Naa15, located in the first three TPR repeat of the protein (which we call
electropositive region 1, EPR1), and the other was in a long, basic α-helix near the C-terminus of
the protein (EPR2) (Figure 5.6C and Figure 5.7A). Intriguingly, both EPR1 and EPR2 are on the
same side of the enzyme, and would orient the active site of Naa10 toward an emerging Nterminus if bound to the ribosome. Moreover, both of these regions are dynamic in crystal
structures of NatA, having high B-factors, and are often positioned in different orientations
compared to the rest of the core of the complex in different structures of NatA (Liszczak et al.
2013; Weyer et al. 2017) (and unpublished data). This may indicate a conformational flexibility
required for these regions to properly orient themselves to interact with the ribosome.
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Figure 5.6 Conservation analysis and electrostatic surface of NatA show two regions
important for ribosome binding
(A) Cartoon representation of the NatA complex. Naa10 is shown in cyan, Naa15 in green, and
the peptide substrate in magenta. The N-terminus and internal basic helix are indicated, as is the
active site where N-termini are acetylated. (B) Conservation map of the NatA complex. Magenta
areas represent regions of high sequence conservation and cyan areas represent regions of low
sequence conservation. (C) Electrostatic potential map of NatA. Blue areas represented regions
that are electropositive, and red areas represent regions that are electronegative.
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In order to test the contribution of EPR1 and EPR2 on ribosome binding, we made a
number of different mutations targeting these regions. (Table 5.1 and Figure 5.7A). We mutated
three lysines to glutamates in EPR1 (K3E), six lysines to glutamates in EPR2 (K6E), and
combined all nine of these mutations into one construct (K9E). We also deleted the first three Nterminal TPR repeats (∆N in Figure 5.7A), and also made a mutant combining this with the
mutations in EPR2 (∆N-K6E). We decided to delete the entire N-terminal domain since this
entire region displayed higher conservation than most of the Naa15 subunit (Figure 5.6B).
The mutations in these regions had negative effects on binding to the ribosome. Both the
mutations targeting lysines in EPR1 (K3E) and EPR2 (K6E) displayed weaker binding to the
ribosome than WT (Figure 5.7B), and combining the two regions together (K9E) displayed an
even greater effect. The ∆N mutations displayed a slightly most severe effect than K9E (Figure
5.7B), and thus the N-terminal region seems to be a major contributor to the interaction. This
suggests that regions in the N-terminus outside of EPR1 in the N-terminus also strongly
contribute to ribosome binding, and that the electrostatic interactions predicted are not a complete
description of the interaction.
We also constructed a number of lysine to glutamate mutations in other regions of Naa15
as controls to test if disrupting other regions of positive charge on the protein would have the
same effect (Figure 5.8A). Two of these mutants (K2EA and K2EC, Table 5.1) behaved as the WT
enzyme (Figure 5.8B), but interestingly, one did not (K2EB, Table 5.1). We do not know why the
mutations of K342E, K345E in NatA (K2EB) are sensitive for ribosome binding, since they are
poorly conserved among NatA orthologues and are not oriented in the same interface as the EPR1
and EPR2 regions we identified. Nonetheless, this data indicates that other surfaces of NatA
outside of EPR1 and EPR1 may also contribute to ribosome binding.
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Table 3.1 NatA mutants used in this study

NatA variant

Mutations in variant

WT

N/A

K3E

K27E, K28E, K31E

K6E

K605E, K606E, K609E, K610E, K612E, K613E

K9E

K27E, K28E, K31E, K605E, K606E, K609E, K610E, K612E, K613E

∆N

∆1-109

∆N-K6E

∆1-109, K605E, K606E, K609E, K610E, K612E, K613E

K2EA

K216E, K217E

K2EB

K342E, K345E

K2EC

K398E, K401E
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Figure 5.7 Pull down analysis of NatA mutants
(A) Location of NatA mutants used in this study. Mutated regions are shown in yellow. Lysines
mutated in K3E and K6E constructs are shown as sticks, and the N-terminal domain deleted in
the ∆N constructs is indicated in yellow. K9E is a combination of the mutations K3E and K6E.
(B) Sedimentation assay with NatA mutants visualized on SDS-PAGE. Naa15 is indicated. Note
that for the ∆N mutants, Naa15 runs lower than WT Naa15. The faint bands above 80 kD in these
lanes is not Naa15, but rather impurities from the ribosome prep. These lanes are marked with
asterisks. The Naa10 band is obscured by the ribosomal proteins in the gel.
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Figure 5.8 Pull down analysis of controls
(A) A surface view of the NatA complex. Mutated lysine residues are indicated in orange and
labeled with their mutant name. (B) Pull down analysis of the NatA mutants visualized on SDSPAGE. Asterisks are used as in Figure 5.7. (C) Activity analysis of mutants. SASE is a peptide
corresponding to a known NatA substrate, and MLGP is a peptide corresponding to a NatE
substrate. Assays were done in triplicate.
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We tested all of the mutants with an activity assay to ensure that they were properly
folded and found that each of the mutants retained catalytic activity within ~2-fold of the wildtype enzyme (Figure 5C). We tested the activity against two different peptides. The first, which
we refer to as SASE, after the four first N-terminal residues, is a strong NatA substrate. The
second, MLGP, is a NatE substrate, which NatA cannot acetylate. We used SASE as a positive
control, and MLGP as a negative control for the folding of the NatA complex. Note that Naa10 is
not active in the absence of Naa15, which wraps around Naa10 and repositions one of its
substrate binding loops. These assays indicate that all of the mutants contained a properly folded
Naa15-Naa10 interaction, and that the ∆N mutant retained activity suggests that this region is not
required for the Naa15-Naa10 interaction. Thermal melts were also performed and demonstrated
that each of the mutants had comparable melting temperature of about 40 oC, consistent with
wild-type folding properties of the mutant proteins (data not shown).
After the co-sedimentation assays, we focused on the ∆N-K6E (Table 1) mutant, since it
displayed one of the most severe pulldown defects. We decided to pursue this mutant even though
the ∆N mutation alone was almost as severe in ablating the interaction (Figure 4B) because due to
the weaker binding of K9E than either K3E or K6E alone, which indicates that this region is
important, despite the N-terminus appearing to be a more crucial region in the interaction. We
performed co-sedimentation over a range of ribosome concentrations to determine the affinity of
this mutant to the ribosome. The resulting data could not be fit to a curve, yet the ribosome only
began significantly pulling down the mutant at 10 µM, which indicates a significant decrease in
affinity between the ribosome and the mutant complex (Figure 5.9A). We also performed gel
filtration with the mutant and observed essentially no binding between the ribosome and the
mutant (Figure 5.9B). These data indicate that the ∆N-K6E mutant (Table 5.1) highly disrupts the
interface between the ribosome and NatA.
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Figure 5.9 ∆N-K6E does not bind to ribosomes
(A) Binding curves of WT NatA and ∆N-K6E using the sedimentation assay shown in Figure 5.2.
∆N-K6E could not be fit to a curve. (B) Comparison of WT and ∆N-K6E eluting with the
ribosome from Superose 6 and visualized on SDS-PAGE. Note that the binding of ∆N-K6E is
weakened. Data for WT NatA has been reproduced from Figures 5.1 and Figure 5.2 for readers
ease.
124

5.3 Discussion and future directions
Here we have presented data on the interaction between the ribosome and NatA. Studies
with purified ribosomes and NatA reveal a salt dependent interaction with dissociation constant
of about 1 µM similar to other enzymes which bind near the exit tunnel of the ribosome (BingelErlenmeyer et al. 2008; Rutkowska et al. 2008; Sandikci et al. 2013). Conservation analysis led
us to identify two regions of the protein important for ribosome binding: the N-terminus, and a
positively charged helix near the C-terminus. Importantly, these regions are on the same side of
NatA, and would orient the active site of Naa10 to face the peptide coming out of the exit tunnel.
The deletion of the entire N-terminus in this work precludes us from specifically identifying the
residues in this region that mediate the interaction. In addition, the finding that the K2EB mutant is
also defective in ribosome binding suggests that this model is still incomplete, and more work
will be necessary to dissect other contributions to the NatA/ribosome interaction.
Other lines of evidence from other recent studies also support the notion that NatA
regions EPR1 and EPR2 are important for ribosome binding. NatA has two known binding
partners, Naa50 and HYPK. The crystal structures of both of these enzymes bound to NatA have
been solved (Neubauer 2012; Weyer et al. 2017), and neither interface would occlude EPR1 or
EPR2 from binding to the ribosome. Naa50 is positioned in such a way that its active site would
similarly face the peptide emerging from the exit tunnel, which is consistent with the model
proposed here. Moreover, the NatB structure, which was also recently reported, shows a similar
molecular “nest” of Naa25 around Naa20 (Hong et al. 2017). The TPR repeats of Naa25 are
arranged differently than Naa15, particularly in the region where the ribosomal binding
determinants are found in NatA. Notably however, there are two regions on Naa25 that contain
positively charged regions in the same positions as Naa15 (Figure 5.11). This suggests that the
mode of ribosome binding could be similar between the different NATs. An open question in the
field is whether the NATs have the same binding site on the ribosome, or if they can bind
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simultaneously. These results, along with the fact that all of the NATs are substoichiometric with
the ribosome in the cell (Raue, Oellerer, and Rospert 2007), may point to the NATs competing
for the same binding sites on the ribosome and quickly sampling the peptides being translated.

Figure 5.10 NatB has positively charged regions in the same configuration as NatA
(A) Cartoon representation of the NatA and NatB complex. Naa10 is shown in cyan and Naa15 in
green. Naa20 is shown in yellow and Naa25 in orange. (B) Electrostatic surface representation of
Naa15 and Naa25 with EPR1 and EPR2 on the Naa15 structure, and putative areas on Naa25
corresponding to these regions indicated with arrows.
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These studies raise a number of questions about the interaction of NatA and the
ribosome. Does NatA compete with the other NATs, and the other N-terminal processing
enzymes, which bind to the exit tunnel. For NatA in particular, methionine aminopeptidase needs
to act on iMet before NatA can acetylate the N-terminus (Van Damme, Evjenth, et al. 2011).
Whether NatA binds simultaneously with MAP and if the presence of one increases the affinity of
the other is an open question. Why did we not see any density for the NAT in the cryo-EM
structure? This could be due to a number of factors. In addition to what was discussed above in
the results section, the other N-terminal processing enzymes are highly dynamic, and
substoichiometric to the ribosome in the cell. Although NatA can bind to the non-translating
ribosome there may be an ordering only upon binding to ribosomes that are translating. It may be
that NatA needs to be trapped with a peptide emerging from the exit tunnel in order for it to be
sufficiently homogeneous for structural studies. Indeed, SRP affinity for the ribosome increases
significantly when there is a peptide emerging from the tunnel (Akopian et al. 2013). Trigger
factor also displays increased affinity and slower on/off kinetics for the ribosome in the presence
of a nascent peptide (Raine et al. 2006; Rutkowska et al. 2008).
To begin to address this issue, we have incorporated p-benzoyl-L-phenylalanine (pBpa)
into NatA using amber suppression (Chin et al. 2002) to specifically crosslink NatA to the
ribosome. Briefly, this method allows for incorporation of unnatural amino acids into proteins by
simultaneously expressing an aminoacyl-tRNA synthetase/tRNA pair targeting amber stop
codons and NatA in E. coli. This allows for site-selective incorporation of pBpa into NatA. pBpa
readily forms covalent crosslinks when exposed to UV light, and if it is in complex with a binding
partner, we reasoned that it could crosslink to the ribosome in a site-specific manner. We made
two mutants of NatA with pBpa substitutions. We made a negative control at position K401, a
residue on the opposite interface of the ribosome binding site that we showed did not affect
ribosome binding if mutated to a glutamic acid (K2EC mutation in Figure 5.8). The other
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mutation was at position K605, located in the charged helix of EPR2 (Figure 5.6). After
irradiating the proteins with UV light in the presence and absence of ribosome, there are a
number of new bands which appear in the 605/ribosome lanes, which do not appear in the protein
lane alone, or in the lanes with WT NatA (lanes 1) or 401 NatA (Figure 5.11). This suggests that
the K605 variant is crosslinking to ribosomal proteins (or rRNA) in a specific manner. While still
low efficiency, and crosslinking validation is necessary, this method may be useful is the future
for stabilizing the complex for cryo-EM studies and for identifying the binding partners in the
ribosome.
Together, these studies provide the first molecular framework for understanding how
NatA interacts with the ribosome for co-translational protein N-terminal acetylation. This work
will allow more research into the significance of co-translational N-terminal acetylation for a
plethora of biological processes.
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Figure 5.11 Crosslinking of p-benzoyl-L-phenylalanine (pBpa)-incorporated NatA with the
ribosome
(A) Gel of crosslinking pBpa labeled NatA with the ribosome. Sample 1 is WT NatA, without
pBpa. Sample 2 is NatA K401pBpa; K401 is one of the lysines from K2EC from Figure 5.8A, as a
negative control. Sample 3 is NatA K605pBpa, a lysine from EPR2, Figure 5.6C. Novel bands are
shown with asterisks, and only show up when K605 and the ribosome are irradiated with UV
light. (B) Complete gel from Figure 5.11A
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5.4 Material and methods
5.4.1 Schizosaccharomyces pombe ribosome purification
Ribosomes were purified from S. pombe based on a modified preparation described for
the S. cerevisiae ribosome (Ben-Shem et al. 2011). S. pombe (strain 972 h-) was grown to an
OD600 of 5 in YPD at 30oC. Cells were pelleted by centrifugation, re-suspended with YP (i.e.
without glucose) and incubated in flasks with vigorous shaking (250 rpm) for 10 minutes. This
glucose starvation step was done to ensure that the ribosomes were not translating protein, and
would be in the apo form when purified. All further steps were performed at 4oC. Cells were
pelleted by centrifuged and washed in buffer M (30 mM Hepes pH 7.5, 50 mM KCl, 10 mM
MgCl2, 8.5% mannitol, 2 mM DTT, 0.5 mM EDTA). Cells were pelleted again, the supernatant
was removed, and the cells were frozen in liquid nitrogen. The cells were lysed using a Mixer
Mill MM 400 (Retsch) and the resulting cell powder was resuspended in buffer M and
supplemented with one complete protease inhibitor tablet (without EDTA, Thermo), 100 µL
RNasin, Pefablock (final concentration 2 mM) and Na-heparin (final concentration 0.8 mg/ml)
The resulting lysate was clarified by centrifugation (31,000g for 9 min). The supernatant was
saved, and PEG 20,000 (Hampton Research) was added to a final concentration of 4.5% w/v and
the solution was left to stand for 5 minutes on ice. The solution was clarified by centrifugation
(20,000g for 5 min) and the supernatant was decanted to a new tube. Residual solution was
“squeezed” out from the pellet by an additional short 1 min. centrifugation. The KCl
concentration was then adjusted to 130 mM. After 5 min on ice, the PEG 20,000 concentrations
were adjusted to 8.5% and the solution was left to stand for 10 min on ice. Ribosomes were
precipitated (17,500g for10 min), the supernatant was discarded and residual solution was
removed by a short spin of the pellet (14,500g for 1 min). The pellets were stored at -80oC until
needed.
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Ribosomes were suspended in buffer M2 (buffer M with KCl concentration adjusted to
150 mM and supplemented with protease inhibitors and heparin). Ribosomes were further
purified by a 15-30% sucrose gradient in buffer A (20 mM Hepes-K pH 7.5, 120 mM KCl, 8.3
mM MgCl2, 2 mM DTT, 0.3 mM EDTA) using a VTi 50 rotor (Beckman) at 40,000 rpm for 1.5
h. After the appropriate fractions were collected based on A260 monitoring, KCl and MgCl2
concentrations were adjusted to 150 mM and 10 mM respectively, PEG 20% was then added to a
final concentration of 7% w/v and the solution was left to stand 10 min. on ice. Ribosomes were
precipitated (17,500g for 10 min), the supernatant was discarded and residual solution was
removed by a short spin of the pellet (14,500g for 1 min.). Ribosomes were suspended (20
mg/ml) in buffer G (10 mM Hepes pH 7.5, 50 mM KOAc, 10 mM NaCl, 2 mM DTT, 5 mM
Mg(OAc)2). The concentrations of ribosomes were determined by the absorbance at 260 nm and
using the extinction coefficient 5×107 cm-1M-1 (Matasova et al. 1991).

5.4.2 Purification of NatA and enzyme assays
NatA was purified and assayed as described (Liszczak et al. 2013) with the following
changes. After the protein was eluted from the nickel column, the His-tag was not cleaved off of
the Naa15 subunit with TEV protease (Naa10 does not have a tag). Leaving the His-tag on the
protein did not affect enzyme activity (data not shown). After elution from the nickel column, the
protein was directly dialyzed into ion exchange buffer containing 25 mM sodium citrate
monobasic pH 5.5, 10 mM NaCl, and 1 mM βME. The subsequent ion exchange and gel filtration
steps were performed as described.
Mutants of NatA were generated using standard site directed mutagenesis using the wildtype NatA as a template. The purification of these mutants was identical to the wild type enzyme.
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Acetylation assays were performed as described (Liszczak et al. 2013). SASE refers to a
NatA substrate, and MLGP refers to a NatE substrate. The first seven N-terminal residues of
these peptides corresponds to protein substrates identified in vivo from proteomic studies and the
remaining residues contain a poly-Arginine track to ensure that the peptides adhere to the
phosphocellulose

used

in

the

assays.

The

full

peptides

are:

SASE-

SASEAGVRWGRPVGRRRRP, and MLGP-MLGPEGGRWGRPVGRRRRP

5.4.3 Sedimentation assays of NatA-ribosome complex
Sedimentation assays were carried out by combining ribosomes and NatA to final
concentrations of 1 µM and 1.2 µM, respectively. 35 µl of this solution was added on top of 80 ul
of Buffer G supplemented with 30% sucrose. Samples were centrifuged at 120,000 rpm in an
S120-AT2 rotor (Thermo) in an ultracentrifuge. The supernatant was removed and ribosomal
pellets were suspended in 110 µl of Buffer G. Samples were run on SDS-PAGE to analyze the
amount of NatA that co-sedimented with the ribosome. When necessary, a Western blot was
performed using an anti-His antibody (GE Healthcare Life Sciences catalogue #27-4710-01)
against the His-tag of the Naa15 subunit. For salt-sensitivity assays, the buffers were
supplemented with the appropriate amount of KCl and performed as described.

5.4.4 Kd determination of NatA-ribosome association
Co-sedimentation assays were performed as above, with the following changes. A total of
120 µl of 30% sucrose was used, and 40 µl of sample was placed on top of that. A constant NatA
concentration of 0.5 µM was used, and ribosome concentration varying from 0.1-11 µM was
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used. A western blot was performed, and the ratio of NatA in the pellet was quantified using
ImageJ. The resulting curve was fit using Prism, and the Kd was calculated using the equation
Y=Kd+0.5+X-sqrt((Kd+0.5+X)^2-2X), where X is the concentration of ribosome in µM, and Y is
the proportion of NatA in the pellet. This equation takes into account the non-negligible
concentration of NatA and ribosome in the experimental set up. It also assumes a 1:1
stoichiometry of NatA:ribosome (see results section for more discussion), and that all of the
ribosomes in the sample are capable of binding to NatA.

5.4.5 Size exclusion chromatography assays
A total of 500 µl of NatA (6 µM) and ribosome (1.8 µM) was injected onto a superpose 6
column and monitored with both 260 nm and 280 nm light. Appropriate fractions were run on
SDS-PAGE and stained with colloidal coomassie blue for imaging.

5.4.6 Preparation and 3D reconstruction of the NatA-ribosome complex
Negative staining and cryo-EM specimen were prepared at the Electron Microscopy
Resource Laboratory (EMRL) at the University of Pennsylvania. The NatA-ribosome complex
was fixed using GraFix (Kastner et al. 2008), a gradient fixation method during which the NatAribosome complex was exposed to a low concentration of a chemical cross-linker (0.25 %
glutaraldehyde) during sedimentation in a sucrose gradient to minimize compositional
heterogeneity and secure the NatA-ribosome interface. To verify the stoichiometry of the
complex, the sedimentation was repeated without fixation and analyzed by SDS-PAGE. The
negative stained samples were prepared on carbon formvar and stained in 2% uranyl acetate
(UA). They were imaged with a FEI Tecnai 12 at 69,680x on a Gatan US1000 high speed
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acquisition camera. The particles were semi-automatically selected with Boxer2 in the EMAN2
software package (Tang et al. 2007) and 2D class averages were calculated using the ISAC
clustering algorithm (Yang et al. 2012) and RELION (Scheres 2012).
The cryo-EM samples were prepared by applying crosslinked NatA-ribosome to carbon
formvar grids with thin carbon, which were then flash frozen in liquid ethane. The cryo-EM data
was collected on a Falcon II direct electron detector (FEI) equipped with an F20 electron
microscope (FEI) operated at 200 kV acceleration voltage at the EMRL. The collected images
stacks were motion corrected with MotionCorr (Li et al. 2013). Cryo-EM particles were again
semi-automatically selected with Boxer2 and the CTF (Contrast Transfer Function) was corrected
in the EMAN2 software package. 2-D class averages were calculated using the ISAC clustering
algorithm and RELION. Once class averages were obtained, five 3D classes were generated using
the program VIPER (SPARX), by using a 60 Å low pass filter model of the ribosome as a
reference (Penczek, Grassucci, and Frank 1994).

5.4.7 Preparation of p-benzoyl-L-phenylalanine labeled NatA and crosslinking assays
Preparation of p-benzoyl-L-phenylalanine (pBpa) labeled NatA was performed by using
site directed mutagenesis on specified NatA residues to TAG (amber stop codons). The plasmid
expressing the aminoacyl-tRNA synthetase/tRNA pair for pBpa was a gift from Dr. James
Petersson from the University of Pennsylvania. This plasmid (streptomycin resistant) was cotransformed into E. Coli with the mutagenized NatA constructs (ampicillin resistant), and was
plated on LB plates containing both antibiotics. Bacteria were grown in minimal media, and upon
reaching an OD of 0.8, p-benzoyl-L-phenylalanine was added to a final concentration of 0.5 mM.
After shaking for 15 minutes to allow for uptake of the unnatural amino acid, the temperature was
reduced to 16 °C, IPTG was added, and the bacteria were grown for 16 hours. After growth, the
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pBpa-incorperated NatA mutants were purified in the same manner at the WT, except everything
was done in the dark to avoid pBpa photoactivation. The crosslinking assays were done by
mixing NatA with the ribosome at 1 µM and 2 µM, respectively, and were irradiated with 365nm
UV light for 30 minutes at 4 °C. Samples were then run on SDS-PAGE, and stained for analysis.
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CHAPTER 6: A Theory on the Evolution of N-terminal Acetylation
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6.1 Why are there NATs?

Throughout the course of graduate school, the most common question I received, and
indeed, the most enduring question in the field, is why are there NATs at all? What is the purpose
of this widespread modification in eukaryotic cells? After all, acetylating the N-terminus of most
proteins, the thinking goes, is energetically costly through the consumption of acetyl-CoA, which
could be used for other cellular processes. Although N-terminal acetylation has been known about
for many decades (Narita 1958; Strous, Westreenen, and Bloemendal 1973), there is still a desire
in the field to find a general reason for its universal presence in eukaryotes. Some early
investigators believed that the general reason was to promote stability and protect proteins from
proteolytic degradation (Jornvall 1975). However, it has long been known that this is not the
general function of the modification. Indeed, papers from the 1970s challenged this view by
showing that this wasn’t the case through early proteomic studies (Strous, Westreenen, and
Bloemendal 1973; Brown 1979). Therefore, although this was an attractive hypothesis, it never
received widespread experimental support.
Since then, the most studied explanation for a general purpose of N-terminal acetylation
has been the Ac/N-end rule. Varshavsky and colleagues discovered the N-end rule in the 1980s,
when they demonstrated that the stability of proteins in the cell depended on their N-terminal
residues. Some residues, like methionine, serine, or alanine, were stabilizing, while others, like
charged or large hydrophobic residues, were destabilizing. These destabilizing N-termini were
deemed N-degrons (Bachmair, Finley, and Varshavsky 1986). Although the N-end rule is not the
only determinant of protein stability (there are hundred of E3 ubiquitin ligases in the human
proteome that target other degrons (Teixeira and Reed 2013)), it does affect half-lives for a
number of proteins (Tasaki et al. 2012). In 2010, it was discovered that acetylated N-termini
could also act as N-degrons, in a new pathway called the Ac/N-end rule (Hwang, Shemorry, and
137

Varshavsky 2010). It is now understood that both free and acetylated N-termini can act as
degradation signals for proteins. The Ac/N-end rule has been shown to regulate the proper
stoichiometry of protein complexes and protein folding (Shemorry, Hwang, and Varshavsky
2013; Park et al. 2015). This is achieved by sterically shielding acetylated N-termini that are
properly folded or are in complex with other proteins. Therefore, unfolded proteins, or those out
of their appropriate complexes in the cell can be preferentially targeted for degradation through
their exposed acetylated N-termini.
This model has since been expanded to bacteria, where all proteins begin with a formylmethionine (fMet) instead of a regular methionine as in archaea and eukaryotes. Although most
peptides are rapidly co-translationally deformylated in bacteria (Kramer et al. 2009), it was
recently proposed by Varshavsky and coworkers that the formyl group on fMet can also act as a
degradation signal (Piatkov et al. 2015). They argue that in bacterial proteins that misfold while
being translated, the formyl group is inaccessible, and peptide deformylase cannot cleave it. The
retained fMet acts as a degradation signal through an unknown mechanism. The formyl group and
acetyl group of bacterial and eukaryotic proteins, respectively, act as analogous degradation
signals at N-termini. Varshavsky and coworkers posit that the slower speed of eukaryotic
translation allows the acetyl group to be added post-translationally, instead of pre-translationally
as in bacteria, and that regulation of protein degradation is, in part, what drove the evolution of Nterminal acetylation (Piatkov et al. 2015).
Although this framework for the evolution and function of NATs has been invaluable for
the field, the Ac/N-end rule has only been observed experimentally in a handful of proteins
(Tasaki et al. 2012; Park et al. 2015). In this chapter, I propose a hypothesis about NAT function
and evolution. I base my reasoning both on Varshavsky’s work, and on an emerging model of
eukaryotic evolution in general. I argue that the evolution of NATs can be explained in part as a
result of the symbiosis between a bacteria cell and an archaeal cell that formed an early
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eukaryote. The NATs arose due to the incompatible types of translational initiation between the
two types of cells, which led to the development of N-terminal acetylation, which only later grew
to obtain its specified function in various systems. If this is the case, the functions of N-terminal
acetylation observed in modern eukaryotes, including protein degradation, are not a driver of the
evolution of the ubiquitous nature of N-terminal acetylation, but rather, the cellular functions are
a result of its ubiquity from evolutionary necessity. In the following sections, I will outline the
history of classifying life, how translation differs between different domains, and new ideas
regarding the emergence of eukaryotes and how this relates to NAT evolution.

6.2 Taxonomy and translation
Before the 1970s, life was broadly divided into two categories: the prokaryotes, which
are morphologically simple, single-celled organism lacking nuclei, and the eukaryotes, which
have true nuclei, membrane bound organelles, and are morphologically complex (Stanier and Van
Niel 1962). Although they share many features indicative of a common ancestor, like a shared
genetic code and basic metabolisms, their fundamental differences indicate that the two groups
had diverged billions of years ago (Woese and Fox 1977).
One of the most fundamental differences is in the way they translate protein. Although
both utilize ribosomes, the ribosome architecture differs between the two groups. This remains
the basis for the use of many antibiotics, which target the 70S bacterial ribosome, but are
innocuous against the 80S eukaryotic ribosome (Wilson 2014). In addition to the differences in
ribosome architecture, the amino acid used to start translation also differs. Prokaryotic cells
initiate translation with fMet, while eukaryotes use regular methionine (Kramer et al. 2009).
Translation is just one of the many differences between prokaryotes and eukaryotes, and because
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of these differences, the two domain system of life was long considered a fundamental part of
phylogenetic taxonomy (Stanier and Van Niel 1962).
However, in 1977, Carl Woese published a landmark paper that upended this view of life
(Woese and Fox 1977). By sequencing 16S rRNA from a number of diverse organisms, Woese
realized that instead of two main branches on the tree of life, there were three. Woese named this
third group archaebacteria, based on the assumption that they were older than what he termed
eubacteria (later shown not to be true). This was a momentous discovery. It reorganized the entire
tree of life based on rRNA sequences alone, and is still used today as one of the fundamental
methods to classify living things.
Archaea had previously been characterized as methanogenic bacteria, as they do not have
nuclei, and are single celled, and morphologically simple. However, biochemically, they are quite
distinct from bacteria (Woese and Fox 1977). They have no peptidoglycan in their cell wall, and
distinct lipids in their cell membranes. Notably, some of their features are closer to eukaryotes
than to bacteria (Table 6.1). Of particular note for us, is that their ribosomes and system of
translation is closer to eukaryotes rather than bacteria. The structure of their ribosomes and
elongation factors more closely resembles eukaryotes, and they do not begin translation with
fMet, but with regular methionine (Cavicchioli 2011).
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Table 4.1 Comparison of features in bacteria, archaea, and eukaryotes.
Table taken from (Barton 2007)

For many years, the placement of archaea and eukaryotes in the tree of life was
challenging; how were the two related? While eukaryotes share many features with archaea, they
also have properties that are closer to prokaryotes (Table 6.1). In addition, certain eukaryotic gene
families had unambiguously evolved from archaeal proteins, while other were from bacteria.
Horizontal gene transfer can obscure phylogenetics for the microbial family tree, and many
different hypotheses abounded (Koonin 2015). Some claimed that eukaryotes were nested within
the archaea, while others maintained that archaea were truly monophyletic (Figure 6.1).
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Ultimately, the answers to these questions, and what guides my hypothesis about NAT evolution,
are beginning to come to light.

Figure 6.1 Competing phylogenetic models concerning the relationship between archaea
and eukaryotes
(A) Model of archaea as monophyletic. The rooted three-domains tree depicts cellular life divided
into three major monophyletic groups or domains: the bacteria, archaea and eukaryota. In this tree
the archaea and eukaryota are most closely related to each other because they share a common
ancestor that is not shared with bacteria. This is the model originally developed by Woese (Woese
and Fox 1977) (B) The rooted eocyte tree recovers the eukaryotic lineage nested within the
archaea as a sister group to the eocytes; this implies that, on the basis of the small set of core
genes, there are only two primary domains of life—the Bacteria and the Archaea. In its modern
formulation shown here the eocyte hypothesis implies that the closest relative of the eukaryotic
nuclear lineage is one, or all, of the TACK archaea. Figure and legend adapted from (Williams et
al. 2013).

142

6.3 NATs driven by eukaryogenesis
In 1967 Lynn Margulis (then Lynn Sagan) proposed her endosymbiosis theory (Sagan
1967). While many aspects of the theory had been written about before (Zimorski et al. 2014),
Margulis used the latest microbiological and biochemical evidence to form the basis of the
modern model of endosymbiosis. She argued that mitochondria and chloroplasts were the results
of symbiosis between an early eukaryotic and prokaryotic cell. That some type of symbiosis did
occur in evolutionary history underlying both mitochondria and chloroplasts is a widely accepted
model today based on the fact that both of these organelles contain their own circular genomes,
contain ribosomes similar to 70S ribosomes from bacteria, and have inner membranes with lipid
composition close to bacterial membranes (Zimorski et al. 2014). There is also the noted
phenomenon of lateral gene transfer, whereby organllar DNA is transferred to the nucleus,
thereby reducing the genomic content of these organelles over evolutionary time (Huang 2013).
In recent years, an adjustment to the hypothesis has emerged based on genomic data,
which has major implications for eukaryotic phylogeny. Instead of an early eukaryotic cell
ingesting a bacterial cell to form these organelles, the origin of eukaryotes itself depended on an
archaeal cell ingesting a bacterial cell, which became an early mitochondrion (Archibald 2015).
Indeed, this event is the driving force behind the development of the eukaryotes as a separate
domain. This reorganizes the tree of life once more, and fundamentally alters the placement of the
eukaryotes (Figure 6.2). Instead of being solely nested within the archaeal lineage, all eukaryotes
evolved from a merger of the two primary domains of life- the bacterial and archaea (McInerney,
O'Connell, and Pisani 2014).
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Figure 6.2 Modern model of eukaryogenesis
Schematic representation of the flow of genetic material from the two major prokaryotic groups
into the base of the eukaryotes and the separate flow of genetic material from cyanobacteria into
plastid-containing eukaryotes (Chloroplast origin). Figure taken from (McInerney, O'Connell, and
Pisani 2014)
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This hypothesis is attractive for many reasons. First, it explains why all eukaryotes have
mitochondria, or belong to lineages that have lost them (Lane and Martin 2010). Second, it
explains why eukaryotes contain a combination of bacterial and archaeal traits and genes. The
early mitochondrion lost many of its genes by lateral gene transfer to the nucleus (Huang 2013).
Third, it explains what drove the evolution of many universal eukaryotic traits. The last common
eukaryotic ancestor (LECA) already had a nucleus, complex vesicular transport, a dynamic
cytoskeleton, and exons and introns (Lane 2017). In order to successfully combine the two
genomes into one organism, changes like formation of a nucleus to separate transcription and
translation were necessary (Lane 2015). Although not universally accepted in scale or scope, this
hypothesis has the support of metagenomic data (Spang et al. 2015) and is a leading model
regarding the evolution of eukaryotes.
How does this inform our understanding of the evolution of the NATs? Comparative
genomic studies show that all of the NATs were present in LECA (Figure 6.3) (Rathore, Faustino,
and Prudêncio 2016), suggesting that their evolution may have been an important part of the
archaeal/bacterial merger. Why would this have been the case? If there was a massive gene
migration event that combined bacterial and archaeal proteins (Huang 2013), then there would
have to be mechanisms to incorporate them into a unified system. As mentioned, bacterial
proteins are translated with an initial fMet, while archaeal proteins are not. Modern eukaryotes
use a translation system derived from archaea, and do not use fMet to initiate translation. The
formyl group is cleaved off on the majority of modern day bacterial proteins. However, a recent
study showed that rapidly folding proteins, or proteins which are secreted or destined for the
membranes retain their formyl group (Ranjan et al. 2017). It would also be a mistake to assume
that the modern day extensive deformylation of proteins seen in model organisms like E. Coli was
necessarily as widespread in early bacteria. Therefore, it is not difficult to imagine bacterial
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proteins that retained the formyl group, and came to depend on it for a variety of reasons, whether
for folding, protein-protein interactions, stability, or localization. However, when these proteins
were expressed in early eukaryote, the translational machinery couldn’t use fMet to initiate
protein synthesis, and therefore, this functional group could not be added before translation
began. As Varshavsky and colleagues noted, however, an acetyl group is quite similar to a formyl
group, and the pool of acetyl-CoA provided a ready supply to take the place of the formyl group
co-translationally instead of pre-translationally (Piatkov et al. 2015). Therefore, due to the
combination of incompatible protein expression system, the ubiquitous fMet in bacteria may have
been replaced with an acetyl group in early eukaryotes.
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Figure 6.3 All six NATs were likely present in the last common eukaryotic ancestor (from
previous page)
Catalytic and regulatory subunits of all six major human NATs complexes were identified across
the eukaryotic tree of life, suggesting they were all present in the LECA. NATs subunit orthologs
were identified in 27 species representative of the eukaryotic tree of life. Naa60 (NatF) was
apparently secondarily lost in fungi. Results are indicated according to reciprocal blastp E-value
score (“filled dot” = E-value score lower than e−8; “open dot” = E-value score between e−8-e−3; “no
dot” = E-value score higher than e−3. Black dot indicates NAT was identified using H.
sapiens ortholog; orange dot indicates that NAT was identified using S. cerevisiae ortholog;
green, yellow and red dots indicate that NATs were identified, respectively, using the
phylogenetically closest plant, excavate and chromalveolata species ortholog. In the case of
species-specific gene duplication, the number of dots is equivalent to the number of identified
NAT paralogs. Figure and legend adapted from (Rathore, Faustino, and Prudêncio 2016).
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One might argue that this line of reasoning only shifts the burden of the presence for a
general function onto fMet in bacteria. I do not believe that this is the case. The evolution of fMet
as the initiating residue can be explained by the uniqueness of the start site of translation. Indeed,
the unique feature in the mRNA around the start codon called the Shine-Dalgarno sequence also
imparts a unique character to the first residue (Nakamoto 2009). Therefore, the use, (or not, as in
archaea) of a unique residue for the first amino acid in a polypeptide does not need, in my view, a
complex explanation as would describing the function of N-terminal acetylation without the
benefit of evolutionary hindsight.
Another potential criticism of this model is the energetic cost associated with acetylating
almost all of the N-termini in the proteome. There are a number of reasons I believe this is not the
case, and that the discussion of this cost of N-terminal acetylation in the literature is
overemphasized without evidence. First, the cost of acetylating proteins in early eukaryotes was
arguably already present from the synthesis of fMet, which also required an input of energy for
all proteins in bacteria. Therefore, instead of creating a new energy cost, the cell was simply
shifting the cost from a formyl-based system to an acetyl-based system. Second, the energetic
cost of protein production is already quite high, and takes up a large portion of the cells energy
reserves (Lane and Martin 2010). Considering the synthesis of each residue, charging of the
tRNA, and elongation factors used, each residue in a protein comes out to about 30 equivalents of
ATP (or GTP) on average (Wagner 2005). The TCA cycle can generate about 13-15 ATP
equivalents from one molecule of acetyl-CoA (Ebenhoh and Heinrich 2001). This is negligible to
the 3000 equivalents used for the synthesis of a 100 residue protein. Finally, the early eukaryotes
may have had an increased overall energy budget from the compartmentalization of the
mitochondria, although this remains a controversial claim (Lane and Martin 2010; Booth and
Doolittle 2015).
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6.4 Mechanism of NAT evolution and specialized NATs
There are NATs in all three domains of life, even though only eukaryotes acetylate most
of their proteome (Aksnes et al. 2016). This suggests that a NAT type enzyme may have already
been present in the early eukaryote after the symbiosis of the archaeal and bacterial cells. If it
were acting to replace the universal fMet on the proteins, this early NAT would have needed a
way to target much of the proteome as it was being translated. It could have evolved a binding
partner that would become the auxiliary subunits of the NATs to allow it to bind to the ribosome
(Figure 6.4A). The early NAT (and modern eukaryotic NATs) necessarily has minimal binding
interactions with few specificity determinants between the enzyme and the peptide in order for it
to bind many different substrates. However, these minimal binding interactions mean a lower
affinity with the substrates. NatA for example, has a KM of about 300 µM for the model peptide
beginning with SASE (Liszczak et al. 2013). This is a poor KM value for a substrate, and many
proteins in the cell that are acetylated by NatA will be well below this concentration. By making
the NAT bind the ribosome, however, the local concentration of substrate is high as it emerges
from the ribosome exit tunnel, and will be more likely to be acetylated (Figure 6.4B). In this
manner, the early NATs may have solved the problem of low affinity by bringing the substrate to
the enzyme on the universal platform of the ribosome.
Interestingly, an archaea, Sulfalobus solfataricus expresses a NAT which can acetylate
both NatA and NatE-type N-termini (Liszczak and Marmorstein 2013). After a small number of
gene duplication events, this early generalist could have evolved into the specialist NATs we see
today, with their substrate specificity directed by the first two residues of the peptide (Figure
6.4C).
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Figure 6.4 Model of NAT evolution (from previous page)
(A) An early promiscuous NAT evolved a binding partner which (B) allowed it to associate with
the ribosome and acetylate nascent peptides. (C) Gene duplication events led to the specialization
observed in the modern NATs. (D) The early NAT also evolved into Naa50 and Naa60 which
took on specialized roles of their own. (E) Due to its unique structural features and substratespecificity, NatD may have evolved from a different GNAT family member, and later converged
on the function of N-terminal acetylation. Figure adapted from (Starheim, Gevaert, and Arnesen
2012).
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Then, once widespread, the evolution of eukaryotic proteins came to depend on the
presence of an acetyl group on the N-terminus, and this quickly became used for different
purposes for diverse proteins. Therefore, instead of one factor driving the evolution of N-terminal
acetylation, it was rather the unique evolution of eukaryotes which caused it to be widespread,
and only later did it become specialized and essential for a number of systems. In this way,
searching for the “general function” of N-terminal acetylation may be a misguided question. Just
because it is widespread does not mean that it has a general function; its widespread nature may
very well be an artifact from the unique evolutionary history of eukaryotes.
This leaves the question of the evolution of the more specialized NATs. Naa50 and
Naa60 are closely related, and both have the classical NAT fold with the β6-β7 loop, which
suggests that they, too, are homologues from an early NAT. However, unlike the major NATs,
this occurred independently of an auxiliary subunit, and each evolved unique features that
allowed it to be specialized (Figure 6.4D). Naa50 associates with the NatA complex and also acts
co-translationally. Naa60’s extended loop regions and C-terminus allow is to be localized to the
Golgi and acetylate membrane proteins. Interestingly, both of these NATs are implicated in cell
division, and have a limited number of substrates compared to the major NATs (Aksnes et al.
2016). What drove the evolution of these NATs is an open question.
NatD, on the other hand, may not have evolved from the same family as the other NATs,
even though it is grouped with them today based on a common function. The lack of the
characteristic β6-β7 loop in this NAT, and extended α1-α2 loop suggest that NatD evolved from
another family of GNAT acetyltransferases, and converged on the function of N-terminal
acetylation (Figure 6.4E). NatD only acetylates H2A and H4, substrates that are highly abundant,
regulated, and also integral to the evolution of eukaryotic gene regulation. From this perspective,
it is therefore not surprising that histones evolved their own dedicated NAT.
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Although deciphering the precise evolutionary pathway of N-terminal acetylation is
difficult, its widespread presence in eukaryotes, similarity in function to iMet formylation in
bacteria, and diverse functional consequences all point to an early adoption in the eukaryotic
lineage. This may be explained by the emerging view that eukaryogenesis resulting from the
symbiosis of a bacterial and archaeal cell, which then needed to evolve ways to overcome this
merger. Future research will undoubtedly uncover additional functions of N-terminal acetylation,
which will guide research tools and therapeutic strategies.
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